Recurrent or chronic depression

F5_DEPRESSION_RECURRENT

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions not (F5_SCHIZO or F5_SCHIZOAFF or F5_BIPO	497596
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — F33 Hospital discharge: ICD-10 — F33 Cause of death: ICD-10 — F33 3 out of 7 registries used, show all original rules.	27123
4. Check minimum number of events None	27123
5. Include endpoints None	27123
6. Filter based on genotype QC (FinnGen only)	27123

Control definitions (FinnGen only)

Control exclude: F5_PSYCH_INCLAVO, ANTIDEPRESSANTS

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF10

NAME	F5_DEPRESSION_RECURRENT
CONTROL_EXCLUDE	F5_PSYCH_INCLAVO\|ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	!(F5_SCHIZO\|F5_SCHIZOAFF\|F5_BIPO)
OUTPAT_ICD	F33
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F33
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F33
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Recurrent or chronic depression based on the number of shared cases.

Similar with more cases:

Depression or dysthymia

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	27123	20275	6848
Unadjusted period prevalence (%)	5.93	6.91	3.02
Median age at first event (years)	43.49	42.04	47.78

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15827: Matched controls
131398

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N06AB08

ATC

fluvoxamine; oral

77.8

323.0

943

107

N07BB01

ATC

disulfiram; oral

28.1

323.0

1240

396

P06

ICPC

Sleep disturbance

6.7

323.0

2165

3026

N05BA01

ATC

diazepam; systemic, rectal

9.4

323.0

3246

3520

N06AA09

ATC

amitriptyline; systemic

12.0

323.0

2431

1950

N06AB03

ATC

fluoxetine; oral

49.3

323.0

4723

1123

A02BC05

ATC

esomeprazole; systemic

2.1

323.0

6265

31349

N06AX26

ATC

vortioxetine; oral

500.9

323.0

2963

H03AA01

ATC

levothyroxine sodium; systemic

2.3

323.0

3606

14701

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

544.3

323.0

870

IGY99

NOMESCO Finland

Other psychiatric treatment contact

888.0

323.0

518

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

323.0

6391

31995

N05CF01

ATC

zopiclone; oral

7.7

323.0

7012

12350

N06AX16

ATC

venlafaxine; oral

132.9

323.0

7248

830

F41.1

ICD-10 Finland

Generalized anxiety disorder

+∞

323.0

1996

R06.0

ICD-10 Finland

Dyspnoea

2.6

323.0

3462

12977

N05BA06

ATC

lorazepam; systemic, sublingual

14.6

323.0

915

551

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

323.0

3145

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

787.2

323.0

461

F40.1

ICD-10 Finland

Social phobias

+∞

323.0

848

SAA01

NOMESCO Finland

Simple examination of mouth

2.3

323.0

11377

69798

N06AA04

ATC

clomipramine; systemic

66.9

323.0

492

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

+∞

323.0

2177

Z73.0

ICD-10 Finland

Burn-out

21.4

323.0

654

264

SPAT1243

SPAT

Psychiatric/psychological examination

58.1

323.0

812

122

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

323.0

4145

17723

SAA02

NOMESCO Finland

Basic examination of mouth

1.9

323.0

10113

62606

N06AX22

ATC

agomelatine; oral

303.1

323.0

1097

F32.0

ICD-10 Finland

Mild depressive episode

+∞

323.0

584

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

+∞

323.0

1534

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.1

323.0

8954

50703

N05AH04

ATC

quetiapine; oral

85.3

323.0

6502

1066

P15

ICPC

Chronic alcohol abuse

38.2

323.0

688

156

N05CF02

ATC

zolpidem; oral

6.7

323.0

4238

6812

M03BX02

ATC

tizanidine; oral

2.1

323.0

10190

61471

N06AX21

ATC

duloxetine; oral

46.9

323.0

4481

1096

N06AX11

ATC

mirtazapine; oral

33.7

323.0

10173

6662

A02BC01

ATC

omeprazole; systemic

2.3

323.0

3907

16316

F10.20

ICD-10 Finland

Alcohol dependence currently independent

+∞

323.0

658

F60.9

ICD-10 Finland

Personality disorder, unspecified

+∞

323.0

449

SPAT1240

SPAT

Therapeutic discussion

20.1

323.0

3314

1706

C07AA05

ATC

propranolol; systemic

4.7

323.0

4029

8968

A02BC03

ATC

lansoprazole; oral

2.3

323.0

4431

19229

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

+∞

323.0

2962

K02.1

ICD-10 Finland

Caries of dentine

2.0

323.0

9081

52551

M54.5

ICD-10 Finland

Low back pain

2.6

323.0

5554

22477

F32.9

ICD-10 Finland

Depressive episode, unspecified

+∞

323.0

6408

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

86.4

323.0

582

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

323.0

5679

23570

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

256.1

323.0

418

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

+∞

323.0

1716

N05BA02

ATC

chlordiazepoxide; systemic

35.4

323.0

540

131

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

+∞

323.0

412

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

522.1

323.0

489

SPAT1307

SPAT

Psychosocial counselling and guidance

13.9

323.0

1344

871

F43.8

ICD-10 Finland

Other reactions to severe stress

+∞

323.0

368

F41.3

ICD-10 Finland

Other mixed anxiety disorders

+∞

323.0

368

N02BE01

ATC

paracetamol; systemic, rectal

2.5

323.0

13194

87821

N06AB10

ATC

escitalopram; oral

81.4

323.0

7899

1588

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

453.0

323.0

631

N06AG02

ATC

moclobemide; oral

76.5

323.0

1748

213

F43.1

ICD-10 Finland

Post-traumatic stress disorder

+∞

323.0

669

F10.24

ICD-10 Finland

Alcohol depence active use

+∞

323.0

386

L03

ICPC

Low back symptom/complaint

2.7

323.0

3855

14143

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

+∞

323.0

4487

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

+∞

323.0

2385

A04

ICPC

Weakness/tiredness general

4.2

323.0

1935

4257

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

1540.7

323.0

379

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

3.8

323.0

1618

3776

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

+∞

323.0

416

N03AX09

ATC

lamotrigine; oral

31.6

323.0

1025

287

M79.6

ICD-10 Finland

Pain in limb

2.3

323.0

5447

24763

SPAT1246

SPAT

Screening of depression or other psychiatric problem

12.3

323.0

750

530

N05BE01

ATC

buspirone; oral

97.0

323.0

1048

N03AX12

ATC

gabapentin; oral

4.2

323.0

2993

6844

N06BA04

ATC

methylphenidate; oral

80.0

323.0

549

F32.8

ICD-10 Finland

Other depressive episodes

+∞

323.0

493

N06AA06

ATC

trimipramine; systemic

56.3

323.0

788

122

P29

ICPC

Psychological sympt/compl other

23.1

323.0

1444

567

R03AC02

ATC

salbutamol; inhalant

2.1

323.0

8208

44705

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.6

323.0

1309

1758

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

782.0

323.0

634

N02AX02

ATC

tramadol; systemic, rectal

2.4

323.0

6736

30623

WX290

NOMESCO Finland

Other blockade of nerve

2.0

323.0

7273

38819

WX110

NOMESCO Finland

Local anesthesy

2.2

323.0

10959

66613

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

6645.8

323.0

771

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

+∞

323.0

345

F43.29

ICD-10 Finland

Adaptation disorder UNS

+∞

323.0

462

F45.8

ICD-10 Finland

Other somatoform disorders

+∞

323.0

1001

F41.00

ICD-10 Finland

Moderate panic disorder

+∞

323.0

507

F34.1

ICD-10 Finland

Dysthymia

+∞

323.0

2331

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

+∞

323.0

2833

AA400

NOMESCO Finland

Electroconvulsive therapy

2932.9

323.0

354

N05BA04

ATC

oxazepam; oral

17.6

323.0

7153

5874

N06AX12

ATC

bupropion; oral

371.9

323.0

3817

113

N03AX16

ATC

pregabalin; oral

4.4

323.0

4910

12282

F99

ICD-10 Finland

Mental disorder, not otherwise specified

+∞

323.0

518

F41.09

ICD-10 Finland

UNS Panic Syndrome

+∞

323.0

692

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3725.8

323.0

445

N05AX08

ATC

risperidone; systemic

100.3

323.0

1175

105

N05AB03

ATC

perphenazine; systemic, rectal

108.3

323.0

651

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.2

323.0

4564

20352

N03AG01

ATC

valproic acid; systemic, rectal

9.8

323.0

919

823

IGY02

NOMESCO Finland

Psychiatric monitoring contact

362.3

323.0

632

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

+∞

323.0

2026

N06CA01

ATC

amitriptyline and psycholeptics; systemic

8.4

323.0

2435

2776

N06AX03

ATC

mianserin; oral

76.7

323.0

1796

219

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

+∞

323.0

449

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

+∞

323.0

1147

N06AX05

ATC

trazodone; oral

136.8

323.0

1004

F41.8

ICD-10 Finland

Other specified anxiety disorders

+∞

323.0

641

N03AE01

ATC

clonazepam; systemic

12.1

323.0

1369

1017

N05AF03

ATC

chlorprothixene; systemic

264.1

323.0

490

A02BC02

ATC

pantoprazole; systemic

2.5

323.0

10249

55859

N06AB06

ATC

sertraline; oral

91.0

323.0

4387

550

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

323.0

632

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

+∞

323.0

6289

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

323.0

795

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

+∞

323.0

481

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1273.3

323.0

722

R51.80

ICD-10 Finland

Headache

3.4

323.0

2538

6955

F33

ICD-10 Finland

Recurrent depressive disorder

+∞

323.0

1740

M79.0

ICD-10 Finland

Rheumatism, unspecified

10.0

323.0

858

747

G47.3

ICD-10 Finland

Sleep apnoea

3.3

323.0

4316

13543

G44.2

ICD-10 Finland

Tension-type headache

3.3

323.0

2228

6255

M54.4

ICD-10 Finland

Lumbago with sciatica

2.7

323.0

2814

9588

F10.25

ICD-10 Finland

Alcohol dependence continuous use

+∞

323.0

419

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

+∞

323.0

4207

P74

ICPC

Anxiety disorder/anxiety state

72.2

323.0

1109

137

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

+∞

323.0

648

A06AD11

ATC

lactulose; oral

3.6

323.0

1761

4421

F10.09

ICD-10 Finland

Alcohol intoxication UNS

+∞

323.0

440

N05AX12

ATC

aripiprazole; systemic

2303.3

323.0

553

M79.7

ICD-10 Finland

Fibromyalgia

13.2

323.0

865

574

N06AX18

ATC

reboxetine; oral

167.5

323.0

489

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

+∞

323.0

429

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

115.9

323.0

1201

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

323.0

3874

16199

AA1AD

NOMESCO Finland

CT of head and brain

2.7

323.0

3171

11173

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

323.0

1114

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

323.0

4445

17194

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.0

323.0

7707

42582

N05BA12

ATC

alprazolam; oral

15.8

323.0

2968

1888

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

+∞

323.0

456

N06AB05

ATC

paroxetine; oral

58.8

323.0

2255

370

N06AX17

ATC

milnacipran; oral

200.9

323.0

470

N05AA02

ATC

levomepromazine; systemic

85.7

323.0

896

P01

ICPC

Feeling anxious/nervous/tense

25.3

323.0

3026

1216

N05AF01

ATC

flupentixol; systemic

50.0

323.0

428

P02

ICPC

Acute stress reaction

8.7

323.0

773

775

F43.0

ICD-10 Finland

Acute stress reaction

+∞

323.0

647

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

+∞

323.0

2935

P03

ICPC

Feeling depressed

54.8

323.0

3746

739

F90.0

ICD-10 Finland

Disturbance of activity and attention

+∞

323.0

655

F51

ICD-10 Finland

Nonorganic sleep disorders

+∞

323.0

547

F32.1

ICD-10 Finland

Moderate depressive episode

+∞

323.0

2256

N05AH03

ATC

olanzapine; systemic

97.4

323.0

1164

107

F39

ICD-10 Finland

Unspecified mood [affective] disorder

+∞

323.0

416

F61.0

ICD-10 Finland

Mixed personality disorders

+∞

323.0

794

P99

ICPC

Psychological disorders other

58.1

323.0

568

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

+∞

323.0

369

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

+∞

323.0

632

F60.5

ICD-10 Finland

Anankastic personality disorder

+∞

323.0

525

R53

ICD-10 Finland

Malaise and fatigue

4.4

323.0

3422

7785

T36

ICD-10 Finland

Poisoning by systemic antibiotics

80.2

323.0

1537

176

N06AA12

ATC

doxepin; systemic

37.4

323.0

1569

386

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

+∞

323.0

515

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

26.7

323.0

3080

1179

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

+∞

323.0

1777

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

+∞

323.0

5273

F43.00

ICD-10 Finland

Acute stress reaction mild

+∞

323.0

471

F32

ICD-10 Finland

Depressive episode

+∞

323.0

2270

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

323.0

7215

38485

R74

ICPC

Upper respiratory infection acute

2.2

323.0

4421

19680

F33.8

ICD-10 Finland

Other recurrent depressive disorders

+∞

323.0

542

N06AB04

ATC

citalopram; systemic

58.6

323.0

7583

2027

P76

ICPC

Depressive disorder

218.5

323.0

3347

161

N05CD07

ATC

temazepam; oral

12.7

323.0

2590

1988

P25

ICPC

Phase of life problem adult

11.8

323.0

873

648

A06AC01

ATC

ispaghula (psylla seeds); oral

2.7

323.0

3771

13529

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

+∞

323.0

4065

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.9

323.0

1995

3135

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

+∞

323.0

356

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.0

322.8

6742

36037

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.2

320.4

4240

18755

M25.5

ICD-10 Finland

Pain in joint

2.1

317.9

4558

20881

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.2

316.5

1926

5467

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.9

312.3

8294

48220

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.8

310.8

2396

7955

L28

ICPC

Limited function/disability (L)

3.1

310.1

2001

5914

N05AL01

ATC

sulpiride; systemic

61.0

309.3

387

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

309.0

5915

30422

R42

ICD-10 Finland

Dizziness and giddiness

2.5

308.1

2894

10766

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

307.2

316

C07AB07

ATC

bisoprolol; oral

2.0

305.3

5937

30679

P20

ICPC

Memory disturbance

4.8

303.6

1129

2081

J02AC01

ATC

fluconazole; systemic

2.0

301.9

6086

31847

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

+∞

301.4

310

M03BC01

ATC

orphenadrine (citrate); systemic

2.2

297.8

3931

17268

E66.01

ICD-10 Finland

Obesity due to excess calories

3.8

293.8

1424

3373

F43.01

ICD-10 Finland

Acute stress reaction moderate

+∞

293.6

302

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.9

291.7

9081

55232

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

290.2

2479

8715

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.8

289.2

1379

3219

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.6

289.1

2517

8945

SPAT1238

SPAT

Brief therapy

24.2

287.1

437

154

L01

ICPC

Neck symptom/complaint

2.8

287.1

2144

6953

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

286.5

2658

9781

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

286.1

5708

29586

Z71.8

ICD-10 Finland

Other specified counselling

2.2

286.1

3467

14602

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

283.8

3226

13170

L17

ICPC

Foot/toe symptom/complaint

2.2

282.1

3541

15142

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

281.9

5506

28267

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.3

281.8

3070

12269

E66.8

ICD-10 Finland

Other obesity

4.6

281.6

1078

2044

M03BC51

ATC

orphenadrine, combinations; systemic

2.0

279.3

4555

21786

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.7

279.2

2196

7341

P01AB01

ATC

metronidazole; oral, rectal

1.9

273.4

5933

31565

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.2

267.5

3326

14113

SPAT1234

SPAT

Support of social functional capacity

8.4

266.5

638

655

SPAT1283

SPAT

Restricted health certificate

2.4

266.4

2789

10892

N01

ICPC

Headache

3.2

265.6

1584

4400

F41

ICD-10 Finland

Other anxiety disorders

+∞

265.3

273

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

+∞

263.3

271

R5140

NOMESCO Finland

Monitoring the use of the aid

2.9

261.2

1804

5541

SPAT1310

SPAT

Counselling related to known health issue

2.0

260.7

4415

21314

A01

ICPC

Pain general/multiple sites

3.9

259.8

1180

2631

D11

ICPC

Diarrhoea

3.0

259.3

1702

5052

N05AN01

ATC

lithium; oral

138.6

258.7

295

A02BA02

ATC

ranitidine; systemic

2.4

258.3

2714

10600

SPAT1216

SPAT

Assessment of functional ability

2.9

254.0

1824

5740

F43.2

ICD-10 Finland

Adjustment disorders

+∞

252.6

260

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.4

250.2

997

1963

IHZ05

SPAT

20.7

247.8

395

162

R06AE07

ATC

cetirizine; oral

1.8

246.6

6649

37694

SPAT1263

SPAT

Sampling

1.8

245.9

5807

31488

SPAT1301

SPAT

No procedures

2.0

245.8

4096

19564

H02AB06

ATC

prednisolone; systemic

1.8

245.2

6620

37522

F60.8

ICD-10 Finland

Other specific personality disorders

+∞

244.8

252

EBA00

NOMESCO Finland

Extraction of tooth

1.9

244.0

4757

24097

N06AA10

ATC

nortriptyline; systemic

12.7

243.4

468

315

IBA03

NOMESCO Finland

Psychotherapy evaluation

721.8

243.4

257

P16

ICPC

Acute alcohol abuse

29.7

243.1

350

100

M01AE02

ATC

naproxen; oral, rectal

1.8

242.5

8561

52756

KMAK

NOMESCO Finland

1.8

241.9

7912

47595

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

241.8

1277

3226

R02

ICPC

Shortness of breath/dyspnoea

2.9

238.5

1646

5037

V03AA01

ATC

25.2

236.8

356

120

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.2

236.3

1408

3893

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.2

235.5

690

954

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.7

235.3

1882

6308

P58

ICPC

Psychological, Therapeutic counselling/listening

21.3

234.8

371

148

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

+∞

234.1

241

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.7

233.9

1849

6153

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.0

232.3

1547

4619

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

+∞

232.2

239

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.4

231.9

2318

8780

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.8

231.7

1675

5276

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

+∞

230.2

237

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

230.1

5376

28872

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

227.5

2459

9677

G43.9

ICD-10 Finland

Migraine, unspecified

4.3

227.1

924

1853

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

226.3

233

R05

ICPC

Cough

2.1

225.4

3100

13613

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.8

225.3

6314

35899

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.9

224.8

4771

24748

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

+∞

223.4

230

J01DB01

ATC

cefalexin; oral

1.8

222.7

12302

85977

R21

ICPC

Throat symptom/complaint

2.2

221.7

2805

11865

N04BC05

ATC

pramipexole; oral

3.8

219.9

1050

2435

S06.0

ICD-10 Finland

Concussion

3.0

219.6

1473

4412

M79.1

ICD-10 Finland

Myalgia

2.6

219.6

1854

6396

XA800

NOMESCO Finland

Neuropsychological investigation

5.1

218.4

751

1261

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.7

217.5

6701

39093

J01DA01

ATC

[U] cefalexin; systemic

1.7

215.6

9307

59918

S18

ICPC

Laceration/cut

1.8

215.5

5653

31347

R01AD09

ATC

mometasone; nasal

1.7

215.0

6795

39904

SPAT1254

SPAT

Administration of medicine

2.6

214.6

1753

5928

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

214.3

5807

32515

L02

ICPC

Back symptom/complaint

3.0

211.7

1375

4026

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

+∞

211.7

218

Z01.2

ICD-10 Finland

Dental examination

1.7

210.7

6128

35020

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

+∞

209.8

216

SPAT1215

SPAT

Assessment of need for medical rehabilitation

5.2

209.4

712

1180

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

207.9

3773

18405

Z08

ICPC

Social welfare problem

24.6

207.6

314

108

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

207.4

3143

14304

M01AB05

ATC

diclofenac; systemic, rectal

1.7

206.6

10162

67505

F60.7

ICD-10 Finland

Dependent personality disorder

+∞

204.9

211

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

22.5

203.5

316

119

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

+∞

202.9

209

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.0

201.2

2971

13360

N05AB01

ATC

dixyrazine; systemic

46.2

201.0

263

UJF32

NOMESCO Finland

Coloscopy

2.0

200.7

3423

16283

N03AX11

ATC

topiramate; oral

8.9

200.6

461

440

SPAT1284

SPAT

Extensive health certificate

6.8

200.6

551

696

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.5

199.6

1728

6026

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

8.4

199.5

474

479

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

199.2

2960

13338

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

+∞

197.1

203

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.6

196.9

1656

5678

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

196.1

202

J01AA02

ATC

doxycycline; systemic

1.7

193.9

11616

80842

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

+∞

193.2

199

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

4.0

192.6

849

1830

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

192.2

198

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

190.5

3304

15771

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

190.3

196

WZA90

NOMESCO Finland

Other doctors statement

1.9

189.7

3344

16054

R52.2

ICD-10 Finland

Other chronic pain

6.1

189.1

560

783

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.3

188.2

1059

2791

A28

ICPC

Limited function/disability NOS

2.8

188.1

1346

4185

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

3.5

187.3

981

2447

R11

ICD-10 Finland

Nausea and vomiting

3.3

186.8

1034

2692

-1

NOMESCO Finland

1.7

186.6

4893

26817

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.9

184.9

3614

17982

SPAT1053

SPAT

Memory test

2.9

184.4

1240

3700

D01

ICPC

Abdominal pain/cramps general

2.6

182.9

1469

4893

SPAT1312

SPAT

General health counselling

1.8

182.4

4229

22264

L08

ICPC

Shoulder symptom/complaint

2.0

181.7

2655

11831

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

181.2

1337

4234

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.4

181.1

983

2519

M01AG02

ATC

tolfenamic acid; oral, rectal

2.1

180.1

2335

9890

OAA65

SPAT

2.5

180.0

1560

5426

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

+∞

179.6

185

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

178.3

2004

7957

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

178.0

1467

4958

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.6

177.3

880

2099

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.5

177.0

1529

5304

SPAT1241

SPAT

Extensive assessment of psychosocial situation

32.0

177.0

250

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

780.1

176.4

186

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

175.6

2648

11930

T82

ICPC

Obesity

4.6

175.4

667

1245

N17

ICPC

Vertigo/dizziness

2.7

173.1

1363

4481

N06AA22

ATC

79.5

172.6

208

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.9

171.9

1152

3424

T90

ICPC

Diabetes non-insulin dependent

1.9

171.8

2841

13253

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.1

171.8

1043

2899

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.8

171.2

3930

20543

M70.6

ICD-10 Finland

Trochanteric bursitis

2.4

170.2

1648

6070

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

+∞

169.8

175

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

+∞

168.9

174

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

168.8

2029

8292

R52.9

ICD-10 Finland

Pain, unspecified

2.8

168.7

1198

3697

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

168.3

7506

47298

L15

ICPC

Knee symptom/complaint

1.9

166.8

2874

13595

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.6

166.1

7492

47278

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

165.8

3711

19206

J01CA04

ATC

amoxicillin; systemic

1.7

165.2

12156

87026

E0000UV

ATC

1.7

164.2

5369

31093

F03

ICD-10 Finland

Unspecified dementia

+∞

164.0

169

J01FA06

ATC

roxithromycin; oral

1.6

163.3

5760

34035

F61

ICD-10 Finland

Mixed and other personality disorders

+∞

163.0

168

J01EA01

ATC

trimethoprim; systemic

1.9

162.8

3049

14846

R06.5

ICD-10 Finland

Mouth breathing

2.5

162.4

1405

4868

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

33.9

162.4

226

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.4

162.4

863

2172

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

+∞

162.1

167

L12

ICPC

Hand/finger symptom/complaint

2.2

161.3

1978

8144

SPAT1260

SPAT

Consultation of another employee

2.1

161.1

2232

9681

A10BA02

ATC

metformin; oral

1.8

160.8

3225

16068

E66.00

ICD-10 Finland

Metabolic syndrome

3.3

160.2

898

2353

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

160.1

165

R03BB04

ATC

tiotropium bromide; inhalant

2.8

160.0

1133

3486

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

160.0

7006

43724

A03CA02

ATC

clidinium and psycholeptics; oral

3.6

159.3

809

1963

R4110

NOMESCO Finland

Physiotherapy

1.8

159.3

3595

18616

K30

ICD-10 Finland

Functional dyspepsia

2.4

159.3

1483

5343

M01AH05

ATC

etoricoxib; oral

1.6

159.1

8996

59789

N05AD03

ATC

melperone; systemic

84.0

158.7

190

D82

ICPC

Teeth/gum disease

1.7

158.0

4989

28536

N02AA05

ATC

oxycodone; systemic

2.3

158.0

1617

6113

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

+∞

157.2

162

M54

ICD-10 Finland

Dorsalgia

2.3

156.7

1576

5903

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

156.4

1678

6488

F06.7

ICD-10 Finland

Mild cognitive disorder

+∞

155.3

160

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.8

154.9

3405

17457

R03BA02

ATC

budesonide; inhalant

2.0

154.5

2475

11357

F41.01

ICD-10 Finland

Severe panic disorder

+∞

154.3

159

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.7

152.9

3966

21391

F05.9

ICD-10 Finland

Delirium, unspecified

+∞

152.3

157

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

1372.2

152.1

159

J45

ICD-10 Finland

Asthma

2.5

151.9

1381

4905

J01CA08

ATC

pivmecillinam; oral

1.6

151.8

4959

28550

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

151.5

2603

12249

C03CA01

ATC

furosemide; systemic

1.9

151.5

2582

12116

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

150.6

1398

5022

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

150.6

3266

16650

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

1352.4

150.2

157

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

9.3

149.4

335

306

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

25.3

149.0

223

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.0

149.0

658

1416

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

148.2

2549

11989

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.5

147.9

1350

4803

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

147.2

2303

10451

Z72.1

ICD-10 Finland

Alcohol use

20.9

147.0

233

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

31.2

146.7

208

K07.60

ICD-10 Finland

Snapping jaw

3.6

146.3

724

1718

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

+∞

144.6

149

R4140

NOMESCO Finland

Psychotherapy

89.7

144.0

171

J01FF01

ATC

clindamycin; systemic

1.7

143.8

3708

19896

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.1

143.8

894

2520

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

143.5

1653

6592

IEY01

NOMESCO Finland

Psychoeducation, individual

635.9

143.5

152

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

142.8

2419

11298

K59.0

ICD-10 Finland

Constipation

3.8

142.3

653

1453

M01AH01

ATC

celecoxib; oral (coxibs)

1.9

140.3

2448

11552

F84.5

ICD-10 Finland

Asperger syndrome

+∞

139.7

144

R01AD08

ATC

fluticasone; nasal

1.7

139.1

4103

22849

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

11.9

138.8

273

193

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

138.2

3978

21992

IER01

NOMESCO Finland

Psychoeducation, group

+∞

137.8

142

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

1225.1

137.6

144

A03FA02

ATC

cisapride; oral, rectal

2.8

137.5

987

3054

R96

ICPC

Asthma

2.5

137.4

1177

4039

N30.0

ICD-10 Finland

Acute cystitis

2.2

137.2

1554

6143

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

137.2

3041

15542

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

136.8

141

R03DC03

ATC

montelukast; oral

1.9

136.3

2285

10615

N03AF01

ATC

carbamazepine; oral, rectal

3.7

136.3

652

1503

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.2

136.2

801

2169

N05CD02

ATC

nitrazepam; oral

15.1

136.2

242

135

M01AX17

ATC

nimesulide; oral

1.7

134.6

3209

16765

Z05

ICPC

Work problem

9.7

134.2

293

255

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

133.7

746

1942

L86

ICPC

Back syndrome with radiating pain

3.1

133.6

806

2222

K59.09

ICD-10 Finland

Constipation, unspecified

3.5

133.5

680

1651

F45.0

ICD-10 Finland

Somatization disorder

+∞

132.9

137

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

+∞

132.9

137

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

132.5

1313

4864

A02BA04

ATC

nizatidine; systemic

2.7

131.8

975

3070

Z02.7

ICD-10 Finland

Issue of medical certificate

3.1

131.8

821

2314

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.2

131.8

755

2005

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

130.7

3122

16297

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

9.5

130.4

288

256

J01FA10

ATC

azithromycin; systemic

1.5

130.3

8714

58874

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

+∞

130.0

134

P80

ICPC

Personality disorder

576.6

130.0

138

Z00.0

ICD-10 Finland

General medical examination

1.9

129.2

2313

10982

SPAT1237

SPAT

Psychotherapy

45.7

129.2

169

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

12.9

129.1

245

160

R05

ICD-10 Finland

Cough

1.8

129.1

2466

11976

SPAT1281

SPAT

Other administrative function

2.6

128.8

1033

3414

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

128.4

1673

7022

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.7

128.2

615

1421

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

+∞

128.0

132

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.5

127.5

1156

4087

P27

ICPC

Fear of mental disorder

31.5

127.3

180

M48.0

ICD-10 Finland

Spinal stenosis

2.3

126.9

1342

5126

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

126.7

4552

26570

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

126.7

1244

4583

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

125.9

1642

6891

D09

ICPC

Nausea

3.9

125.3

568

1249

Z29

ICPC

Social problem NOS

9.8

125.1

272

235

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

124.9

2379

11525

SPAT1265

SPAT

Breathalyser

23.8

124.9

190

M01AC06

ATC

meloxicam; systemic, rectal

1.6

124.8

5145

31039

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.4

124.4

1144

4073

N07BA03

ATC

varenicline; oral

3.0

124.3

782

2216

N06DX01

ATC

memantine; oral

40.9

124.3

166

F52.2

ICD-10 Finland

Failure of genital response

+∞

124.2

128

J01MA02

ATC

ciprofloxacin; systemic

1.6

123.8

4801

28522

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.8

123.2

899

2806

F50.9

ICD-10 Finland

Eating disorder, unspecified

+∞

122.2

126

E66.9

ICD-10 Finland

Obesity, unspecified

4.1

122.0

515

1062

J20

ICD-10 Finland

Acute bronchitis

2.3

121.9

1233

4605

S29

ICPC

Skin symptom/complaint other

1.9

121.7

2014

9277

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.5

121.6

1070

3720

R03AC03

ATC

terbutaline; inhalant

1.9

121.4

1939

8816

IGV01

NOMESCO Finland

Psychiatric network contact

+∞

121.2

125

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

+∞

121.2

125

R55

ICD-10 Finland

Syncope and collapse

2.4

121.1

1144

4127

M54.2

ICD-10 Finland

Cervicalgia

2.6

121.0

995

3331

E66

ICD-10 Finland

Obesity

3.3

121.0

677

1764

R06AX27

ATC

desloratadine; oral

1.6

120.5

3878

21945

U02

ICPC

Urinary frequency/urgency

2.1

120.5

1500

6165

R51

ICD-10 Finland

Headache

3.2

120.3

712

1934

IHZ02

SPAT

98.4

120.0

141

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

119.9

1383

5495

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

119.5

10073

70865

K59.1

ICD-10 Finland

Functional diarrhoea

3.3

119.2

652

1671

C07AB02

ATC

metoprolol; systemic

1.9

118.9

2087

9814

N06DA02

ATC

donepezil; oral

36.7

118.6

162

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

118.2

1733

7616

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.7

117.9

2915

15310

M02AA07

ATC

piroxicam; topical

1.6

117.9

4746

28372

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

117.6

1432

5828

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.5

117.4

5187

31684

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

117.1

1937

8913

L13

ICPC

Hip symptom/complaint

1.9

116.7

1848

8364

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

116.7

2779

14431

H01

ICPC

Ear pain/earache

2.2

116.4

1370

5489

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

+∞

116.4

120

R07.3

ICD-10 Finland

Other chest pain

2.3

116.3

1171

4360

G47.9

ICD-10 Finland

Sleep disorder, unspecified

5.7

116.3

361

535

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

+∞

115.4

119

SPAT1229

SPAT

Assessment of need for aid

2.8

115.2

841

2624

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

114.8

5111

31237

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

+∞

114.4

118

C08CA01

ATC

amlodipine; oral

1.6

114.4

4017

23191

A29

ICPC

General symptom/complaint other

2.2

114.3

1278

5002

L16

ICPC

Ankle symptom/complaint

2.2

114.2

1324

5268

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.7

114.1

835

2609

N05BA05

ATC

potassium clorazepate; oral

24.4

114.0

172

UKC02

NOMESCO Finland

Cystoscopy

2.0

113.7

1595

6884

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

18.1

113.5

188

SPAT1235

SPAT

Mental health, emotional support

45.9

113.3

148

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.9

113.3

1832

8350

OAB93

SPAT

4.1

113.3

481

997

A01AB09

ATC

miconazole; local oral

2.3

113.2

1119

4125

K04.0

ICD-10 Finland

Pulpitis

2.1

112.4

1397

5731

SPAT1389

SPAT

Visit based on need for special support

9.3

112.0

250

227

D06

ICPC

Abdominal pain localized other

2.5

111.6

1003

3521

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

5.4

111.5

364

573

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.6

111.5

902

2989

D10

ICPC

Vomiting

3.0

111.1

717

2064

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

110.8

2207

10812

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

492.1

110.7

118

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

+∞

110.6

114

N76.0

ICD-10 Finland

Acute vaginitis

3.4

110.5

579

1435

A05

ICPC

Feeling ill

2.8

110.5

771

2337

TAB00

NOMESCO Finland

Lumbar puncture

3.3

110.2

601

1536

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.2

110.1

1322

5339

N89

ICPC

Migraine

4.6

110.1

416

769

A11

ICPC

Chest pain NOS

2.6

110.0

913

3068

A06AC51

ATC

ispaghula, combinations; systemic

3.1

109.7

659

1808

D19

ICPC

Teeth/gum symptom/complaint

1.6

109.7

3622

20546

A03

ICPC

Fever

1.8

109.3

2039

9769

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

109.2

13814

105387

WX002

NOMESCO Finland

Sedation and analgesia

1.8

108.8

2419

12270

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

+∞

108.6

112

H02AB07

ATC

prednisone; oral

1.9

108.3

1832

8478

G04BD12

ATC

mirabegron; oral

2.4

108.0

1056

3869

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

+∞

107.6

111

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

107.6

3462

19490

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

107.4

791

2478

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

107.3

2498

12844

WX722

NOMESCO Finland

PEEP

3.1

107.2

651

1799

L29

ICPC

Musculoskeletal sympt/complt other

2.5

107.2

961

3366

A99

ICPC

Disease/condition unspecnature/site

2.5

107.0

958

3355

D07AC01

ATC

betamethasone; topical

1.5

106.2

4415

26443

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

6.0

106.1

314

438

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

106.1

1284

5201

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

4.2

106.1

442

900

R00.2

ICD-10 Finland

Palpitations

2.5

105.9

924

3190

M54.6

ICD-10 Finland

Pain in thoracic spine

2.5

105.8

930

3225

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

105.7

109

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

14.3

105.5

191

112

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

105.4

1707

7772

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

105.4

3615

20667

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

195.6

105.4

117

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.3

105.1

1050

3886

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

104.7

2614

13710

R01AD12

ATC

fluticasone furoate; nasal

1.5

104.3

4136

24480

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

104.2

1383

5823

SPAT1252

SPAT

Overall medication plan or its review

2.8

103.5

752

2336

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.9

103.2

1740

8034

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

103.2

1461

6315

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

+∞

102.8

106

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

102.7

2091

10296

C05AA08

ATC

fluocortolone; rectal, topical

1.8

102.2

1915

9171

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

101.6

1172

4643

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.6

101.5

500

1179

R03BA01

ATC

beclometasone; inhalant

1.9

101.0

1806

8509

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.3

100.9

553

1418

SFA00

NOMESCO Finland

Small filling

1.9

100.8

1784

8375

G03DB01

ATC

dydrogesterone; oral

1.9

100.7

1770

8291

E000001

ATC

1.7

100.4

2573

13579

D07AA02

ATC

hydrocortisone; topical

1.9

99.9

1751

8192

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

+∞

99.9

103

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.9

99.5

1568

7057

H02AB04

ATC

methylprednisolone; systemic

1.8

98.9

1894

9130

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

+∞

98.9

102

K08.80

ICD-10 Finland

Toothache NOS

2.2

98.8

1073

4133

A97

ICPC

No disease

1.9

98.5

1771

8356

N05AD01

ATC

haloperidol; systemic

8.2

98.4

235

240

T74.1

ICD-10 Finland

Physical abuse

6.3

98.3

283

381

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.1

98.2

587

1603

R29

ICPC

Respiratory symptom/complaint other

2.5

97.5

841

2881

K10.3

ICD-10 Finland

Alveolitis of jaws

3.0

97.3

625

1794

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.4

97.2

927

3348

SPAT1262

SPAT

Handing over of treatment supplies

1.8

97.0

2047

10181

F34.0

ICD-10 Finland

Cyclothymia

+∞

97.0

100

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

+∞

97.0

100

N05AC02

ATC

thioridazine; oral

11.4

96.9

194

143

R03BA05

ATC

fluticasone; inhalant

1.7

96.7

2333

12085

M54.3

ICD-10 Finland

Sciatica

2.5

96.1

802

2698

SPAT1227

SPAT

Substance abuse rehabilitation

36.5

96.0

131

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

+∞

96.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

95.8

1383

6015

SPAT1058

SPAT

PEF monitoring instruction

2.3

95.4

1011

3847

SBB10

NOMESCO Finland

Teeth copy

2.4

95.1

872

3087

J01MA12

ATC

levofloxacin; systemic

1.7

94.9

2118

10712

G04BD04

ATC

oxybutynin; oral, transdermal

3.1

94.8

582

1620

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

94.8

1189

4881

N06DA03

ATC

rivastigmine; oral, transdermal

50.6

94.3

121

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

94.3

2743

14963

P18

ICPC

Medication abuse

92.8

94.0

111

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

7.9

94.0

231

247

R1250

NOMESCO Finland

Evaluation of functional capability

4.9

93.8

330

566

R35

ICD-10 Finland

Polyuria

2.8

93.7

661

2015

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

93.7

3403

19635

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

93.5

929

3423

A02BC04

ATC

rabeprazole; oral

2.1

93.3

1148

4671

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

6.4

92.9

263

346

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.5

92.5

475

1158

LCA06

NOMESCO Finland

Biopsy of endometrium

1.9

92.2

1643

7716

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.8

92.1

1905

9400

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

92.1

1237

5221

R20.2

ICD-10 Finland

Paraesthesia of skin

2.4

92.0

838

2955

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.5

92.0

468

1133

B02AA02

ATC

tranexamic acid; systemic

1.7

92.0

2079

10547

R13

ICD-10 Finland

Dysphagia

2.6

91.9

718

2327

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

91.8

933

3478

D02

ICPC

Abdominal pain epigastric

2.6

91.4

742

2458

V03AB30

ATC

25.3

91.2

136

M03BX01

ATC

baclofen; systemic

6.5

91.0

254

328

SPAT1360

SPAT

Extensive global examination

2.4

90.7

839

2982

K08.3

ICD-10 Finland

Retained dental root

2.4

90.7

855

3069

WZA10

SPAT

43.2

90.3

119

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

+∞

90.2

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.4

90.2

478

1195

R05FB02

ATC

cough suppressants and expectorants

1.5

90.1

4861

30555

P28

ICPC

Limited function/disability (P)

70.1

89.3

109

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

89.3

1995

10079

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

+∞

89.2

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

+∞

89.2

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

+∞

89.2

Z06

ICPC

Unemployment problem

12.2

88.9

172

118

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

88.9

2865

16019

R06AX13

ATC

loratadine; oral

1.7

88.7

2082

10672

N03AF02

ATC

oxcarbazepine; oral

3.8

88.7

405

896

309

Kela drug reimbursment

Nalmefene and naltrexone

80.5

88.4

106

S21

ICPC

Skin texture symptom/complaint

1.9

88.1

1413

6387

SPAT1153

SPAT

Removal of sutures

1.5

88.1

3832

22991

C10AA01

ATC

simvastatin; oral

1.5

88.0

4499

27937

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.3

87.9

895

3338

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.8

87.4

397

874

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

87.4

1041

4172

N02CC04

ATC

rizatriptan; oral

2.4

87.3

806

2862

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

4450

17664

2.00

320.99

1.4

499.7

587.4

titre

2.05

828

3609

(3000850) Epithelial cells [#/volume] in Urine

5193

21779

1.91

319.15

2.7

2.4

7.1

5.7

e6/l

7.88

4533

18934

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2922

9855

2.29

319.11

2.8

2.4

34.7

40.2

u/l

2.12

2501

8560

(3032080) INR in Blood by Coagulation assay

8624

42205

1.73

318.96

6.5

7.0

1.1

1.2

inr

9.09

2675

12363

(3021601) Nitrite [Presence] in Urine by Test strip

11917

63749

1.67

315.67

4.9

4.2

0.0

estimate

0.36

2453

11490

(3021387) Prolactin [Units/volume] in Serum or Plasma

1816

4911

2.80

312.54

1.6

319.3

282.2

mu/l

1.20

1612

4528

(3009261) Glucose [Presence] in Urine by Test strip

11992

64372

1.67

312.22

3.7

3.0

0.0

estimate

0.46

2384

11164

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2411

7542

2.45

310.88

3.0

3.8

4.5

4.6

pmol/l

5.15

2113

6950

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

730

71.44

307.65

1.7

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

7981

34285

2.00

307.65

3.3

3.1

8.1

8.0

mmol/l

0.66

6779

29670

(3027944) Amphetamines [Presence] in Urine

2903

5338

4.31

307.65

2.2

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5233

21062

2.01

307.65

1.3

1.2

7.4

13.2

u/ml

8.90

1990

8820

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6868

13331

4.76

307.65

2.0

1.3

1.5

1.2

126.34

6100

12211

(42870588) Differential panel, method unspecified - Blood

8901

40142

1.94

307.65

5.6

6.2

—

(4198724)

379

103

26.97

307.65

2.1

1.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

12562

61583

1.95

307.65

5.8

5.9

29.6

29.2

3.70

11695

58104

(3019550) Sodium [Moles/volume] in Serum or Plasma

23319

138330

4.40

307.65

15.4

11.0

139.6

139.8

mmol/l

39.76

22859

134551

(3035350) Ketones [Presence] in Urine by Test strip

11950

63269

1.70

307.65

3.7

3.0

0.0

estimate

1.90

2385

11121

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

21420

99876

4.91

307.65

4.9

3.6

14.2

14.7

pmol/l

184.71

20006

92029

(3019150) Specific gravity of Urine by Refractometry

6064

26083

1.90

307.65

3.7

3.2

1.0

kg/l

0.15

717

4230

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

12153

48004

2.62

307.65

2.5

2.2

7386.0

76.5

nmol/l

0.50

11214

44349

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3966

14528

2.16

307.65

2.3

2.5

2.4

g/l

11.94

3605

13705

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

8500

38989

1.87

307.65

3.5

2.7

47.4

42.9

ng/l

0.14

4648

22639

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23074

122973

5.81

307.65

6.0

4.0

2.0

2.2

mu/l

0.54

21942

114320

(3028300) Cannabinoids [Presence] in Urine

3019

5349

4.50

307.65

2.3

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

6767

19054

3.15

307.65

1.5

1.4

20.3

20.5

nmol/l

0.67

5968

16499

(3031040) Bacteria [#/volume] in Urine by Automated count

15852

81385

2.12

307.65

4.8

3.4

1080.9

1197.4

e6/l

0.11

199

978

(3019309) Folate [Moles/volume] in Red Blood Cells

5470

12800

3.67

307.65

1.8

1.6

1139.3

1152.8

nmol/l

0.46

4356

9836

(1001926) Buprenorphine [Presence] in Urine by Screen method

2643

3336

6.28

307.65

2.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3623

11406

2.51

307.65

2.2

1.8

—

(3018010) Neutrophils/100 leukocytes in Blood

12416

60691

1.95

307.65

5.6

5.7

56.2

56.4

1.45

11602

57513

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23925

154011

4.07

307.65

11.5

8.4

27.6

26.8

u/l

6.46

23364

149354

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

13139

58995

2.29

307.65

5.7

6.2

9.7

11.1

umol/l

53.97

12291

56212

(3011288) Drugs identified in Urine by Screen method

2664

2262

9.41

307.65

3.2

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5543

17852

2.60

307.65

2.3

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

4683

15665

2.43

307.65

2.3

2.7

106.1

138.3

ug/g

8.40

3620

12716

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6148

26322

1.91

307.65

1.8

0.9

1.1

mg/l

3.83

4448

20042

(3001604) Monocytes [#/volume] in Blood

13082

62237

2.09

307.65

5.7

0.5

0.6

e9/l

4.45

11399

54731

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12509

50914

2.56

307.65

6.2

6.7

1.2

mmol/l

0.35

10695

43427

(3023323) Follitropin [Units/volume] in Serum or Plasma

2415

7169

2.59

307.65

1.4

1.3

23.9

29.5

iu/l

12.80

2042

6296

(3019198) Lymphocytes [#/volume] in Blood

13511

64733

2.11

307.65

5.6

5.7

2.0

1.9

e9/l

2.73

11993

57937

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4200

16063

2.07

307.65

3.5

3.8

0.8

mmol/l

1.17

3924

15208

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

11648

38717

3.20

307.65

2.1

1.7

98.8

98.1

pmol/l

0.74

6415

20215

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

21693

131449

2.49

307.65

12.3

9.5

90.7

86.5

ml/min/173m2

157.02

18131

107029

(3037467) Urinalysis macro (dipstick) panel - Urine

16608

88608

2.06

307.65

4.5

3.6

—

(40761511) CBC panel - Blood by Automated count

23527

152782

3.02

307.65

13.7

9.2

—

(3028707) Methadone [Presence] in Urine by Screen method

2118

376

44.38

307.65

2.5

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

18654

94408

2.70

307.65

4.3

3.7

10.5

mm/h

0.25

17449

88536

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7267

24097

2.66

307.65

2.3

2.1

2.8

mg/l

1.99

6232

20997

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4756

16542

2.33

307.65

2.4

3.2

2.4

mmol/l

31.10

4101

14651

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

20654

122475

2.28

307.65

5.8

4.5

38.8

38.7

mmol/mol

0.17

19446

115441

(3006315) Basophils [#/volume] in Blood

13138

62477

2.10

307.65

5.7

5.8

0.0

e9/l

4.55

11426

54904

(3015377) Calcium [Moles/volume] in Serum or Plasma

9337

33692

2.60

307.65

2.7

3.8

2.3

2.4

mmol/l

9.34

8259

30128

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11421

45563

2.50

307.65

5.5

5.9

1.2

mmol/l

1.32

10464

41655

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7793

28629

2.41

307.65

1.4

1.2

2.0

u/ml

7.27

2051

8345

(3006504) Eosinophils/100 leukocytes in Blood

12107

58826

1.95

307.65

5.8

5.9

2.9

0.60

11233

55452

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2957

8771

2.63

307.65

2.1

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3753

8855

3.43

307.65

2.0

2.4

367.8

377.4

nmol/l

1.90

3408

8274

(3024561) Albumin [Mass/volume] in Serum or Plasma

10884

45628

2.28

307.65

4.6

5.0

36.7

36.3

g/l

14.61

10094

42821

(3007164) IgA [Mass/volume] in Serum or Plasma

6639

24910

2.26

307.65

1.5

1.4

2.2

2.3

g/l

2.75

3917

16308

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6041

20163

2.54

307.65

2.5

1.9

—

(3002582) Erythrocytes [#/volume] in Urine

7243

32683

1.85

307.65

3.3

2.9

48.3

73.6

e6/l

1.43

5526

24505

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22948

141855

3.13

307.65

14.8

10.1

19.1

22.5

mg/l

50.01

18611

106735

(3030467) Casts [#/volume] in Urine by Automated count

6747

29614

1.89

307.65

3.2

2.8

0.3

0.4

e6/l

1.90

5073

21643

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8767

34220

2.31

307.65

2.9

2.4

55.2

59.3

u/l

5.98

8072

31989

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

18641

96060

2.60

307.65

3.9

2.5

45.5

40.9

u/l

8.92

17621

91577

(40768797) Stomach Pathology biopsy report

4058

15029

2.14

307.65

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7633

29871

2.22

307.65

2.2

1.9

214.4

186.9

u/l

0.59

7202

28189

(3000764) Benzodiazepines [Presence] in Urine

3009

5262

4.56

307.65

2.3

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

18885

93984

2.87

307.65

7.6

7.1

75.3

75.8

u/l

1.01

17839

89034

(3019069) Monocytes/100 leukocytes in Blood

12161

59143

1.95

307.65

6.0

6.1

8.1

8.5

33.11

11372

56103

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5542

22319

2.02

307.65

1.3

1.2

24.1

34.6

iu/ml

5.44

1512

7483

(3013650) Neutrophils [#/volume] in Blood by Automated count

14674

72633

2.12

307.65

7.4

8.4

4.0

3.9

e9/l

7.06

12851

63903

(3013115) Eosinophils [#/volume] in Blood

13494

64794

2.10

307.65

5.8

0.2

e9/l

2.78

11932

57756

(3018418) pH of Serum or Plasma

7580

29521

2.23

307.65

3.7

4.3

7.4

2.47

1371

5528

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1267

1440

6.64

307.65

1.4

1.2

—

(3018095) Leukocytes [#/volume] in Urine

8659

40231

1.85

307.65

3.9

3.2

56.9

78.7

e6/l

3.34

6005

26974

(3022948) Iron [Moles/volume] in Serum or Plasma

4331

15879

2.17

307.65

2.3

2.5

14.1

14.0

umol/l

0.71

3996

14987

(3021589) Normoblasts [#/volume] in Blood

11240

57188

1.76

307.65

8.9

8.3

0.0

e9/l

1.94

9161

47541

(36304419) Bacteria [Presence] in Urine

6665

29241

1.88

307.65

3.2

2.7

—

(3016879) Cocaine [Presence] in Urine

2906

4654

4.97

307.65

2.3

1.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

13726

68364

2.00

307.65

5.0

4.2

6.5

6.6

mmol/l

2.95

12760

62405

(3026008) Bacteria identified in Urine by Culture

6966

31353

1.84

307.65

3.0

2.4

—

(3022096) Basophils/100 leukocytes in Blood

11676

56891

1.91

307.65

5.9

6.0

0.7

0.23

10851

53677

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14031

54749

2.95

307.65

3.3

2.6

88.4

112.9

ug/l

23.42

13124

51875

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

6727

30214

1.83

307.65

1.7

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10198

40090

2.42

307.65

3.5

3.1

32.2

32.7

u/l

0.13

9634

38387

(46235355) HIV 1 and 2 tests - Meaningful Use set

7091

32165

1.83

307.65

2.1

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

22102

131956

2.86

307.65

4.6

3.6

5.8

mmol/l

16.75

20706

123086

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6002

19305

2.64

307.65

1.7

1.5

22250967.5

49952059.6

pmol/l

3.25

5101

16540

(3044889) 12 lead EKG panel

15870

87111

1.87

307.65

3.5

3.0

—

(3027008) Opiates [Presence] in Urine

3008

5345

4.49

307.65

2.2

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

23346

138947

4.39

307.65

15.5

11.1

3.9

mmol/l

43.44

22837

134853

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3603

13485

2.09

303.30

2.4

2.6

23.1

23.7

2.01

3158

11725

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

335

171

14.33

301.76

2.2

1.3

179.7

85.0

umol/l

2.76

190

(40758558) Short blood count panel - Blood

6590

30291

1.78

299.38

5.7

6.7

—

(3026782) Osmolality of Urine

4774

19879

1.91

297.17

2.8

2.5

533.2

560.2

mosm/kgh2o

11.25

4077

16995

(3033658) Prothrombin time (PT) actual/Normal

6479

29690

1.78

296.98

4.3

3.6

96.5

93.4

19.90

6262

28992

(36660697) Celiac disease serology panel - Serum

2885

10023

2.22

292.21

1.2

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

446

402

8.14

283.83

1.8

1.1

1.7

0.9

promille

12.71

344

328

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3318

12407

2.07

278.15

5.5

6.7

1.0

mmol/l

0.28

3116

11758

(3017143) Hepatitis C virus Ab [Presence] in Serum

4273

17530

1.92

275.85

1.7

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1189

2751

3.23

266.36

1.4

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1485

3964

2.81

260.51

1.9

1.6

—

(3013512) EKG study

6494

30723

1.71

260.05

3.6

3.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2662

9569

2.13

245.29

1.2

118.2

163.9

iu/ml

7.21

949

3885

(3007853) Bacteria identified in Skin by Aerobe culture

3305

12901

1.98

243.92

1.8

1.6

—

(1002224) Polysomnography panel

1818

5560

2.47

243.69

1.1

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2016

6515

2.34

239.48

2.3

5129.2

5906.9

u/l

0.49

661

2995

(3019225) pH of Specimen

2629

9490

2.12

239.35

3.7

4.1

—

(3023368) Bacteria identified in Blood by Culture

5664

26315

1.72

238.84

4.4

3.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3245

12695

1.97

237.52

2.8

6.5

7.8

umol/l

4.06

2687

11225

(3009343) pH of Capillary blood

1722

5209

2.49

235.97

3.1

3.2

7.4

0.98

199

670

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2601

9412

2.11

235.08

2.4

0.2

g/l

2.83

2379

8946

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1738

5290

2.48

235.07

3.1

3.2

5.2

5.1

kpa

4.04

1621

4908

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

17767

108995

1.62

234.15

3.9

3.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1058

2502

3.15

228.30

1.4

287.6

279.9

ug/g

0.33

554

1444

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1658

5005

2.49

227.97

3.1

1.4

1.5

mmol/l

1.33

1212

3627

(3009214) Lutropin [Units/volume] in Serum or Plasma

1421

4031

2.64

221.40

1.4

1.3

9.5

10.0

u/l

0.67

1134

3395

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4178

18196

1.79

218.02

2.7

2.5

1.0

e6/l

0.25

2241

10153

(3002385) Erythrocyte distribution width [Ratio]

19384

122602

1.64

210.61

16.7

12.2

13.5

1.16

19012

120059

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1997

6785

2.22

210.11

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3166

12801

1.90

208.38

6.5

5.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2346

8570

2.08

205.45

2.6

2.0

12.1

12.9

nmol/l

4.53

2057

7913

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3910

17041

1.78

201.99

2.8

2.6

4.2

3.0

e6/l

5.72

1978

9066

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3537

14983

1.82

200.63

1.9

1.7

—

(3007461) Platelets [#/volume] in Blood

24419

167463

3.68

197.89

21.8

14.3

267.2

255.1

e9/l

158.67

24035

163164

(3029937) Albumin [Presence] in Urine by Test strip

6531

32810

1.59

196.62

4.1

3.3

0.0

estimate

0.04

2400

11137

(3011397) Hemoglobin [Presence] in Urine by Test strip

5770

28187

1.62

194.60

3.7

3.1

—

(3035941) MCH [Entitic mass]

24426

167716

3.65

192.63

21.6

14.2

30.2

30.1

1.56

24216

165720

(3026361) Erythrocytes [#/volume] in Blood

24429

167767

3.65

192.10

21.7

14.3

4.5

4.6

e12/l

51.77

24000

163124

(3024731) MCV [Entitic volume]

24426

167742

3.64

191.86

21.7

14.2

90.4

90.2

8.32

24216

165737

(3010813) Leukocytes [#/volume] in Blood

24429

167822

3.64

190.46

21.8

14.3

6.8

6.5

e9/l

47.52

24003

163124

(3000963) Hemoglobin [Mass/volume] in Blood

24431

167881

3.63

189.36

21.8

14.3

135.8

137.3

g/l

55.94

24221

165884

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1967

6937

2.14

187.96

1.1

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

6072

30273

1.59

187.06

4.0

4.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1162

3237

2.67

186.96

3.3

24.8

24.7

mmol/l

0.16

1097

3003

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

870

2071

3.11

185.29

1.4

1.3

24.5

28.2

u/l

2.23

687

1779

(3022313) Gas panel - Capillary blood

1269

3724

2.54

184.07

3.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

937

2340

2.97

184.03

1.3

453.9

537.4

mg/l

3.11

893

2244

(3023183) Ammonium ion [Moles/volume] in Plasma

661

1321

3.69

183.80

3.2

2.9

35.5

34.4

umol/l

0.29

576

1163

(3025941) Bacteria identified in Stool by Culture

1991

7118

2.11

183.57

1.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

702

1481

3.49

180.51

1.5

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

21941

144935

1.78

179.73

4.8

4.1

2.9

mmol/l

2.50

20530

136568

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9099

50136

1.49

174.93

3.8

3.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1473

4770

2.31

172.43

1.3

1.2

0.4

1.0

u/ml

2.51

115

391

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

843

2057

3.03

172.16

1.2

1.3

3.7

3.6

mmol/l

1.64

790

1938

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

791

1858

3.14

172.09

1.6

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

845

2071

3.02

171.27

1.4

1.5

1105.8

1373.0

e6/l

0.33

685

1656

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

843

2068

3.01

170.59

1.4

26.9

38.4

e6/l

0.49

655

1574

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4207

19561

1.67

169.14

3.6

3.1

310.2

678.0

ng/l

4.76

2544

13694

(3013139) Helicobacter pylori Ag [Presence] in Stool

2136

8085

1.99

168.31

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2115

8067

1.98

162.86

6.8

7.8

1.3

mmol/l

1.54

2027

7827

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5164

25486

1.58

162.42

2.8

830.6

1013.2

ng/l

2.11

4133

21672

(4010399)

2078

7926

1.98

159.88

1.5

1.4

—

(3022145) Colonoscopy Study observation

3144

13686

1.75

159.85

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

21662

143496

1.69

159.43

4.4

3.8

4.8

mmol/l

14.21

20387

136159

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

902

2397

2.78

158.30

2.1

1.8

192.1

199.3

pmol/l

1.03

840

2321

(3005322) IgE [Units/volume] in Serum or Plasma

2207

8636

1.93

157.59

1.3

221.2

241.6

u/ml

0.37

2043

8059

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2110

8146

1.95

156.67

4.1

4.0

5.9

5.8

kpa

4.52

2042

7950

(3009466) Valproate [Moles/volume] in Serum or Plasma

312

373

6.11

156.58

2.9

327.2

377.7

umol/l

4.57

253

308

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1471

4956

2.22

156.51

1.1

11.6

6.5

u/ml

0.19

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2228

8770

1.92

156.26

2.4

2.3

20.7

23.1

au/ml

0.37

112

674

(3042936) Bacteria identified in Isolate by Culture

3436

15453

1.70

155.18

2.1

1.9

—

(3044640) Blood type and Crossmatch panel - Blood

7414

39915

1.49

155.06

2.4

2.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2858

12222

1.78

154.01

7.1

7.5

104.3

104.8

mmol/l

6.22

2805

11987

(3012544) pH of Venous blood

2165

8500

1.92

152.86

4.1

4.0

7.4

0.25

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

21517

142631

1.66

152.13

4.4

3.7

1.4

1.5

mmol/l

107.52

20168

135014

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2070

8022

1.94

151.81

1.3

49.6

49.3

au/ml

0.02

383

(3002032) Base excess in Venous blood by calculation

2091

8136

1.93

151.55

4.2

4.0

1.8

mmol/l

0.05

1723

6750

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

20870

137430

1.60

149.58

3.9

3.4

1.4

1.3

mmol/l

115.15

19447

129755

(3005719) IgG [Mass/volume] in Serum or Plasma

2250

9045

1.88

147.66

2.3

2.8

10.3

10.7

g/l

3.71

2021

8375

(3003327) Ova and parasites identified in Stool by Light microscopy

1302

4289

2.26

145.94

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1196

3799

2.34

145.77

1.9

1.6

37.4

40.6

nmol/l

4.47

1165

3735

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2399

9928

1.82

143.46

1.8

1.6

—

(3000494) Fungus identified in Specimen by Culture

3106

13881

1.70

142.58

1.5

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1715

6375

2.01

141.18

1.1

123.9

220.1

titre

0.91

215

(3024354) Oxygen [Partial pressure] in Venous blood

1738

6492

2.00

141.16

3.6

3.2

4.8

4.7

kpa

0.97

1671

6318

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2005

7918

1.90

138.52

3.5

3.7

1.2

mmol/l

2.61

1698

7069

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2395

10018

1.80

138.03

1.8

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3425

15892

1.65

135.87

2.1

2.3

29.4

29.6

1.44

3322

15451

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6240

33236

1.48

133.56

1.7

1.6

1.5

1.3

mmol/l

40.75

5326

28562

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

10748

63387

1.40

130.41

4.0

3.8

—

(3000991) Gas panel - Venous blood

1951

7831

1.87

127.85

8.3

9.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1027

3234

2.35

127.38

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1028

3243

2.35

126.98

1.2

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5309

27614

1.49

126.73

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

6003

32066

1.46

125.12

2.3

2.4

2616.1

4007.9

umol/l

2.69

5204

28799

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1015

3207

2.34

124.91

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

737

2000

2.71

124.14

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1214

4176

2.16

122.09

4.4

4.6

24.2

24.1

mmol/l

0.16

1087

3808

(40768804) Tissue Pathology biopsy report

9522

55448

1.39

121.82

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5638

30000

1.46

118.82

2.3

2.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

6198

33614

1.44

118.01

4.1

4.0

8.3

8.6

mg/mmol

0.18

3891

21362

(3012516) Albumin [Mass/volume] in Urine

5933

31953

1.45

117.09

3.3

365.0

395.5

mg/l

0.19

3786

19941

(3027945) Reticulocytes/100 erythrocytes in Blood

2290

10006

1.72

112.40

2.3

2.8

1.8

1.7

1.14

1995

9108

(40761535) Cells panel - Urine sediment

1977

8307

1.78

111.11

3.6

3.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1737

7020

1.85

110.83

1.8

1.3

g/l

0.05

1574

6508

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1536

5970

1.91

110.46

1.7

1.6

3.3

3.4

mg/l

0.30

1235

3814

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1262

4581

2.04

110.16

1.6

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

201

219

6.68

109.74

1.0

843.9

804.9

ng/l

0.42

127

153

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

776

2300

2.48

109.57

1.5

1.4

0.4

0.5

nmol/l

0.45

607

1829

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

201

220

6.64

109.31

1.0

33.6

33.8

ng/l

0.02

130

152

(3027801) Oxygen [Partial pressure] in Arterial blood

2358

10486

1.69

108.32

7.6

7.8

12.3

13.5

kpa

25.66

2272

10040

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2358

10491

1.69

108.12

7.6

7.9

5.1

kpa

1.57

2273

10049

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

199

220

6.58

107.28

1.0

247.0

423.3

ng/l

0.54

130

158

(3041096) Erythrocytes [Presence] in Urine by Automated

6563

36476

1.41

107.00

3.2

2.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1321

4933

1.99

106.57

1.7

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3916

19786

1.51

104.97

1.8

1.7

—

(3003396) Base excess in Arterial blood by calculation

2344

10504

1.68

104.43

7.7

7.8

0.9

mmol/l

0.46

1853

8203

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5172

27729

1.44

102.28

1.5

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

387

808

3.50

100.96

1.6

2.2

20.0

18.7

nmol/l

1.72

357

781

(3009542) Hematocrit [Volume Fraction] of Blood

20924

140535

1.47

100.12

15.3

10.4

40.3

40.5

4.80

15962

113059

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2971

14273

1.57

99.64

4.2

3.9

30.2

32.3

21.88

2248

10204

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

874

2852

2.26

99.63

2.3

2.5

349.9

527.3

ug/l

0.89

797

2661

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1408

5533

1.89

97.66

1.5

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1730

7300

1.76

95.30

3.5

4.2

78.8

89.5

ng/l

4.85

1495

6481

(3006653) Thiamine [Moles/volume] in Blood

239

368

4.73

92.51

1.4

1.3

137.4

135.3

nmol/l

0.24

239

368

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1753

7491

1.74

92.34

2.3

2.1

6.5

8.6

ug/l

2.72

1486

6777

(3016502) Oxygen saturation in Arterial blood

2086

9349

1.67

92.34

8.2

8.4

95.7

96.3

4.94

2032

8980

(3022217) INR in Platelet poor plasma by Coagulation assay

2511

11887

1.58

89.03

17.8

19.2

1.2

inr

0.61

342

1945

(3008898) HLA-B27 [Presence]

1300

5162

1.86

87.11

1.1

—

(1616796) Gas panel - Central venous blood

634

1912

2.43

86.21

3.1

3.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3359

17078

1.49

85.64

1.8

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1426

5874

1.80

84.90

6.5

7.9

24.8

24.7

mmol/l

0.74

1410

5837

(3023410) Appearance of Cerebral spinal fluid

405

976

3.03

84.32

1.5

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2461

11741

1.57

84.12

1.5

—

(3010421) pH of Blood

716

2310

2.28

83.74

3.4

7.4

4.88

618

1955

(3016244) Insulin [Units/volume] in Serum or Plasma

343

751

3.33

83.35

3.6

3.3

34.3

25.3

mu/l

3.07

322

707

(3035637) Corticotropin [Mass/volume] in Plasma

475

1266

2.74

82.71

1.5

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

594

1778

2.45

82.07

1.3

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

447

1158

2.82

82.02

1.3

18.2

28.6

nmol/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1038

3901

1.96

81.88

1.8

1.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

594

1780

2.44

81.87

1.3

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1879

8480

1.65

80.52

7.9

8.9

7.8

9.0

mmol/l

11.71

1794

8154

(3001019) Free T4 and TSH panel - Serum or Plasma

1956

8947

1.63

79.44

1.7

1.6

—

(40761536) Microorganisms panel - Urine sediment

2184

10267

1.59

79.26

4.0

3.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

938

3441

2.01

79.18

1.3

65.8

145.5

titre

3.71

352

(3012501) Base excess in Blood by calculation

634

1993

2.33

78.68

3.4

2.4

mmol/l

0.14

423

1322

(3013290) Carbon dioxide [Partial pressure] in Blood

634

1994

2.33

78.59

3.4

5.1

4.9

kpa

3.55

618

1953

(3027315) Oxygen [Partial pressure] in Blood

637

2016

2.32

77.85

3.4

9.0

8.9

kpa

0.79

621

1975

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1063

4097

1.91

77.85

3.4

2.9

1.5

1.2

14.99

1057

4073

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

964

3603

1.97

77.20

1.3

34.3

44.3

u/ml

0.53

247

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1362

5730

1.76

75.32

1.4

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

922

3424

1.98

75.17

1.2

1.3

709.0

1221.0

titre

1.10

118

(3019060) Gas panel - Arterial blood

1336

5593

1.77

75.13

5.4

5.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

699

2338

2.19

74.99

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

582

1808

2.36

74.17

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

526

1565

2.46

73.61

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1721

7765

1.65

73.58

1.3

1.5

—

(3020891) Body temperature

909

3385

1.98

73.53

5.2

4.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1034

4025

1.89

73.45

3.4

2.9

0.7

0.77

1001

3879

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1002

3900

1.89

71.17

1.8

1.2

g/l

4.19

959

3729

(3048929) Epstein Barr virus Ab [Presence] in Serum

1210

5000

1.79

71.03

1.2

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

281

603

3.39

70.47

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

830

3044

2.00

70.05

2.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

977

3792

1.90

69.98

1.8

0.2

g/l

0.23

933

3610

(3017732) Neutrophils [#/volume] in Blood

1901

8905

1.59

69.64

2.3

4.0

4.1

e9/l

0.51

1461

7289

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1889

8877

1.58

68.22

8.7

124.0

122.1

g/l

3.50

1838

8534

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

292

662

3.21

67.27

1.3

1.2

5.3

5.7

umol/l

0.89

260

618

(3008402) Methanol [Moles/volume] in Serum or Plasma

19.61

67.18

1.2

1.1

—

mmol/l

—

(3016018) Differential panel - Cerebral spinal fluid

398

1083

2.68

66.68

1.4

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

747

2687

2.04

66.47

1.2

1.3

40.9

46.3

u/ml

0.34

275

(3004119) Hemoglobin [Mass/volume] in Venous blood

1297

5582

1.72

66.03

3.6

3.3

132.7

130.4

g/l

3.07

1265

5467

(3002179) Metamyelocytes/100 leukocytes in Blood

1903

9056

1.56

64.96

3.4

4.1

0.5

0.6

2.39

364

1930

(3023520) Reticulocytes [#/volume] in Blood

1594

7274

1.62

64.90

2.4

2.9

74.1

70.3

e9/l

3.28

1162

5466

(3021440) Promyelocytes/100 leukocytes in Blood

1977

9507

1.55

64.41

3.6

4.3

0.1

0.52

434

2456

(3000492) Spirometry study

2708

13906

1.46

64.20

1.5

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

2047

9936

1.53

63.90

3.6

4.3

0.8

0.9

1.86

469

2618

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1340

5879

1.68

63.53

9.3

9.9

1.5

1.3

10.53

1335

5850

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1164

4914

1.75

63.40

9.0

10.5

24.2

24.3

mmol/l

0.33

1087

4672

(3003181) Sodium [Moles/volume] in Urine

410

1171

2.55

62.48

1.5

1.3

59.5

66.6

mmol/l

2.39

309

953

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1206

5170

1.72

62.21

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

671

2377

2.07

62.19

1.3

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

368

999

2.69

61.96

1.2

1.1

37.9

45.8

mg/l

2.20

306

851

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2141

10570

1.51

61.63

3.5

2.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

61.34

1.4

0.0

527.9

—

nmol/l

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

864

3365

1.89

61.18

1.3

5.8

9.2

u/ml

0.86

118

543

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

12.85

60.86

1.1

1.2

46.7

39.0

mg/l

1.09

(3028626) Oxygen [Partial pressure] in Capillary blood

559

1860

2.20

60.74

2.9

2.8

8.6

8.5

kpa

0.71

520

1725

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

359

974

2.69

60.53

1.1

251.1

262.0

mg/l

0.26

316

871

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1134

4816

1.73

60.45

1.3

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

619

2164

2.09

59.40

2.8

24.3

24.5

mmol/l

0.49

550

1895

(4027681)

308

778

2.88

59.23

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

846

3321

1.87

58.46

1.3

4.6

7.7

u/ml

0.61

360

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1224

5364

1.68

58.18

2.0

2.2

40.2

39.8

u/l

0.28

1106

4893

(3025159) Blasts/100 leukocytes in Blood

1866

9073

1.52

57.55

3.7

4.3

0.1

0.3

2.20

374

2116

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

341

934

2.66

56.48

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

484

1564

2.26

56.41

1.9

1.8

3367.0

2334.2

titre

0.33

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

949

3906

1.78

56.30

1.1

3.2

5.8

u/ml

2.16

130

611

(3008295) Osmolality of Serum or Plasma

290

729

2.90

56.27

1.8

1.4

280.0

281.2

mosm/kgh2o

0.38

210

604

(3020630) Protein [Mass/volume] in Serum or Plasma

1594

7548

1.56

55.32

2.1

2.7

67.1

67.0

g/l

0.26

1440

7055

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

236

532

3.23

54.95

1.1

4.1

7.7

nmol/l

0.44

109

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

427

1340

2.32

53.26

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

423

1325

2.33

52.98

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

423

1325

2.33

52.98

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

423

1325

2.33

52.98

1.3

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

543

1890

2.10

52.72

2.3

17.2

16.8

1.28

268

951

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

365

1073

2.48

52.48

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

432

1375

2.29

52.18

1.3

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

425

1352

2.29

51.40

1.3

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

241

576

3.04

51.05

1.6

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

235

556

3.07

50.63

1.5

1.4

22.1

28.7

umol/l

2.43

223

529

(3028271) Lactate [Moles/volume] in Capillary blood

423

1358

2.27

50.10

1.8

1.6

1.8

1.7

mmol/l

1.24

412

1326

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

872

3623

1.77

50.08

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

207

457

3.29

49.85

1.3

1.5

511.9

535.2

mu/l

0.07

199

441

(44813793)

328

939

2.54

49.83

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

210

469

3.25

49.67

1.3

1.5

72.5

72.0

0.19

202

453

(3004588) Protein electrophoresis panel - Serum or Plasma

1294

5994

1.59

49.23

1.9

2.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

663

2544

1.91

49.09

4.8

4.3

3.8

3.9

mmol/l

4.38

633

2399

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

456

1538

2.16

47.98

1.2

1.3

0.1

0.3

nmol/l

2.17

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1218

5616

1.60

47.22

8.4

7.0

24.6

24.5

mmol/l

0.49

1156

5178

(3024891) Influenza virus A+B Ag [Presence] in Specimen

813

3367

1.77

47.20

1.2

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

676

2645

1.87

47.18

1.2

8.5

16.3

u/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

978

4268

1.68

47.11

3.6

3.3

25.2

25.3

mmol/l

0.30

954

4141

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1934

9856

1.45

46.95

2.4

74.4

69.7

ml/min/173m2

4.85

746

3558

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

909

3897

1.71

46.75

4.0

3.6

51.2

48.2

2.88

900

3858

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

368

1147

2.34

46.66

2.1

1.9

22.6

25.5

mg/l

0.43

106

290

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

683

2713

1.84

45.47

1.2

1.3

1.6

6.2

u/ml

1.97

220

(3022806) Fractional oxyhemoglobin in Capillary blood

358

1118

2.33

45.21

1.8

1.6

90.6

90.8

0.15

351

1101

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

449

1548

2.12

44.73

1.3

0.6

2.1

nmol/l

0.92

429

1498

(3021901) Oxygen saturation in Capillary blood

446

1534

2.12

44.70

2.6

2.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

780

3248

1.76

44.44

1.1

1.2

2.1

u/ml

1.85

326

1314

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

925

4051

1.67

43.96

1.4

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2237

11839

1.40

43.95

3.4

5.0

224.9

244.6

u/l

9.66

2101

11374

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

546

2042

1.95

43.62

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

780

3268

1.75

43.51

1.2

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

195

453

3.13

43.37

1.7

1.8

1.9

umol/l

0.09

178

427

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

913

4002

1.67

43.24

1.6

422.1

347.2

titre

0.21

153

(3024928) Oxygen saturation in Venous blood

522

1930

1.97

43.09

3.8

3.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

288

836

2.51

42.60

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

546

2065

1.93

42.23

1.5

1.6

0.7

0.8

g/l

1.07

418

1580

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

286

834

2.49

41.92

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

547

2080

1.92

41.64

1.1

—

(3025130) Human papilloma virus identified in Specimen

588

2304

1.86

40.88

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

404

1386

2.12

40.79

1.3

—

(3036489) Thrombin time

1042

4803

1.59

40.38

2.1

2.3

21.0

21.3

0.87

895

4125

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

205

512

2.91

40.38

1.5

1.6

1.8

7.9

nmol/l

0.74

152

437

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

946

4262

1.63

40.26

2.0

1.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

703

2933

1.75

39.80

1.1

6.2

6.1

u/ml

0.05

374

1557

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

286

856

2.43

39.71

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1073

5026

1.57

38.82

1.3

1.7

5.2

14.1

u/ml

4.01

190

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

768

3318

1.69

38.39

1.9

2.0

15.5

10.2

iu/l

0.17

268

1355

(3006270) Folate [Moles/volume] in Blood

257

743

2.51

38.39

1.2

1.1

390.8

380.2

nmol/l

0.33

234

665

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

248

705

2.56

38.34

1.1

u/l

0.28

315

(3037121) Protein [Mass/volume] in Urine

825

3638

1.66

38.18

3.0

3.4

0.3

g/l

0.21

322

1673

(3045414) Leukocytes [Presence] in Urine

1147

5486

1.53

37.80

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

923

4198

1.61

37.80

1.8

1.9

1.5

g/l

0.00

797

3610

(3008401) Mugwort IgE Ab [Units/volume] in Serum

668

2798

1.74

37.32

1.1

1.0

1.2

u/ml

0.36

290

1201

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

141

294

3.48

37.15

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

225

619

2.64

37.13

1.3

1.5

6.8

5.6

u/l

0.42

178

527

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

852

3825

1.63

36.77

1.9

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

702

3001

1.71

36.48

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1166

5654

1.51

36.04

1.3

245.0

224.5

miu/ml

0.98

501

2874

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

156

356

3.18

35.80

1.5

2.5

0.8

1.1

ug/l

0.92

145

336

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

169

405

3.03

35.80

1.8

29.0

29.6

umol/l

0.33

162

395

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

236

678

2.53

35.75

1.4

1.3

—

(3003338) MCHC [Mass/volume]

19232

132207

1.22

35.42

18.2

12.1

332.9

333.1

g/l

3.18

19109

131235

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

663

2814

1.72

35.36

1.2

1.3

279.0

257.7

u/ml

1.04

443

1867

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

152

345

3.20

35.20

1.3

1.4

12.7

15.7

pmol/l

4.89

129

301

(4062490)

357

1248

2.08

34.42

1.4

1.3

—

(3017509) Phencyclidine [Presence] in Urine

110

5.20

34.37

1.4

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

355

1245

2.07

33.94

1.3

0.3

0.4

g/l

3.66

255

867

(3028192) IgG subclass 2 [Mass/volume] in Serum

355

1245

2.07

33.94

1.3

2.9

3.0

g/l

0.50

254

869

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

214

602

2.58

33.85

1.1

9.6

10.8

u/ml

0.18

115

(3019420) Tryptase [Mass/volume] in Serum or Plasma

239

710

2.45

33.80

1.4

1.6

6.3

8.4

ug/l

1.70

214

648

(43055514) Macroprolactin [Presence] in Serum or Plasma

153

358

3.10

33.75

1.3

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

652

2795

1.70

33.56

1.1

2.8

2.2

u/ml

0.39

164

677

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

380

1375

2.01

33.41

1.2

1.3

—

nmol/l

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

354

1248

2.06

33.39

1.3

6.3

6.9

g/l

2.30

252

871

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

7.52

32.83

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

303

1012

2.18

32.82

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

501

2003

1.82

32.75

2.1

2.2

9.1

6.7

titre

0.30

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

248

764

2.36

32.44

1.2

1.9

2.0

mmol/l

0.55

229

715

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

270

867

2.26

32.14

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

838

3873

1.58

32.10

2.4

2.8

178.3

180.9

0.39

799

3686

(3036180) Methadone [Presence] in Urine

+∞

32.04

2.6

0.0

—

(21494755) Public health laboratory ask at order entry panel

2434

22297

0.77

31.87

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

178

3.99

31.32

1.3

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

570

2420

1.72

30.41

1.9

2.2

0.0

g/l

0.87

519

2254

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

612

2653

1.68

30.26

1.9

2.1

38.5

38.2

g/l

0.56

537

2360

(3006184) Hemoglobin [Mass/volume] in Capillary blood

536

2251

1.74

29.74

2.1

133.8

132.0

g/l

0.86

384

1618

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

128

292

3.18

29.49

2.4

2.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

358

1328

1.96

29.42

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

273

916

2.17

29.29

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

657

2929

1.64

29.19

2.0

2.3

0.5

0.8

g/l

1.78

581

2605

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

604

2635

1.67

29.18

1.9

2.2

0.0

g/l

0.21

552

2463

(40768443) Skin Pathology biopsy report

1072

5341

1.47

28.99

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

392

1508

1.89

28.96

1.4

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

548

2339

1.71

28.71

2.7

2.2

0.9

0.8

nmol/l

3.98

452

2012

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

271

915

2.15

28.64

1.1

290.3

290.8

mg/l

0.03

233

844

(3007463) Buprenorphine [Presence] in Urine

+∞

28.37

5.6

0.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

425

1692

1.83

28.23

1.1

1.5

g/l

0.28

380

1545

(3011985) Renin [Units/volume] in Plasma

406

1599

1.85

27.91

1.6

80.3

60.1

mu/l

0.78

355

1452

(3014133) Dog dander IgE Ab [Units/volume] in Serum

558

2413

1.69

27.87

1.1

5.9

4.1

u/ml

0.84

213

957

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

713

3283

1.59

27.78

1.8

2.2

3.0

3.1

g/l

1.37

570

2621

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

521

2216

1.71

27.66

1.1

20.7

11.7

au/ml

0.96

179

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

555

2402

1.68

27.64

1.9

2.2

0.0

g/l

0.00

514

2253

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

749

3500

1.56

27.39

2.1

2.3

10.7

10.6

mg/l

0.14

701

3300

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

700

3222

1.59

27.32

1.9

2.2

9.8

10.4

g/l

3.35

596

2776

(3028679) Herpes simplex virus Ab [Presence] in Serum

237

775

2.22

27.12

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1405

7441

1.39

27.10

2.6

2.7

121.3

160.2

ng/l

4.01

1254

6692

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

743

3475

1.56

27.07

1.8

2.2

7.1

7.3

g/l

2.33

587

2674

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

741

3472

1.56

26.79

1.9

2.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

414

1665

1.81

26.64

1.2

1.3

44.6

59.3

u/ml

0.53

110

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

379

1485

1.86

26.50

1.4

336.5

298.9

pmol/l

0.95

296

1169

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

153

412

2.69

26.47

1.6

1.3

883852.8

2944144.0

iu/ml

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

508

2173

1.70

26.44

1.2

94.3

157.5

titre

—

(3016038) Potassium [Moles/volume] in Urine

165

463

2.58

26.35

1.4

1.2

33.8

36.2

mmol/l

0.54

132

415

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

103

220

3.39

26.33

1.4

1.1

110.6

114.0

nmol/l

0.09

180

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

488

2068

1.72

26.27

2.8

3.2

—

(3014271) Vancomycin [Susceptibility]

113

257

3.19

26.22

3.0

2.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2102

19171

0.77

26.16

1.6

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

737

3468

1.55

26.15

1.9

2.2

3.7

3.8

g/l

1.00

563

2534

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

425

1736

1.78

25.99

1.3

—

(3002256) Pathology report gross observation

2911

17154

1.26

25.99

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

124

301

2.99

25.85

1.2

1.3

25.0

18.8

0.29

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

691

3218

1.57

25.67

1.4

1.5

22.4

12.6

iu/ml

0.63

(3013676) Sertraline [Moles/volume] in Serum or Plasma

+∞

25.63

1.3

0.0

190.0

—

nmol/l

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

653

3006

1.58

25.49

2.0

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

533

2337

1.66

25.31

2.1

2.3

5.2

6.2

umol/l

1.04

406

1702

(3017315) Amylase [Enzymatic activity/volume] in Urine

180

542

2.41

24.88

1.4

1.2

346.8

359.1

u/l

0.04

170

505

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1112

5741

1.42

24.86

2.8

2.5

0.3

e6/l

0.77

1080

5558

(3023430) Cat dander IgE Ab [Units/volume] in Serum

515

2255

1.66

24.60

1.1

6.5

4.8

u/ml

0.60

218

954

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

487

2102

1.69

24.55

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

497

2158

1.68

24.50

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

643

2987

1.57

24.16

1.4

1.5

22.3

22.4

u/ml

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

863

4272

1.48

24.12

2.2

2.4

94.4

93.1

0.79

796

3987

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

806

3941

1.49

23.95

2.7

2.9

3.7

3.6

g/l

0.54

763

3769

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3171

19024

1.23

23.94

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

435

1833

1.73

23.94

1.6

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

+∞

23.80

1.3

0.0

188.0

—

nmol/l

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

641

2999

1.56

23.36

1.4

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

121

308

2.85

23.28

1.1

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

154

446

2.50

23.15

1.2

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

168

509

2.39

22.96

1.1

1.3

62.3

71.3

0.43

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

311

1202

1.88

22.77

1.2

59.8

63.8

u/l

0.51

207

818

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

258

940

1.99

22.44

1.3

0.3

1.4

u/ml

2.59

108

386

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

218

749

2.11

22.18

2.1

2.3

101.8

97.5

0.98

203

685

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

714

3460

1.51

22.18

2.2

2.0

2.3

2.5

ug/l

0.13

637

3130

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

156

465

2.43

22.10

1.3

0.3

g/l

0.25

128

379

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

129

350

2.67

22.09

1.2

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

166

510

2.36

22.03

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

137

385

2.58

21.91

2.5

2.3

55.8

50.5

umol/l

1.26

118

327

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2908

25093

0.82

21.83

3.6

3.5

21.6

21.8

0.39

1094

10361

(3022621) pH of Urine by Test strip

1465

8077

1.33

21.76

2.8

2.5

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

115

296

2.81

21.72

1.1

5.5

6.8

mg/g

1.81

109

282

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

112

285

2.85

21.60

1.1

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

205

2936

0.50

21.56

1.4

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

250

916

1.98

21.43

1.2

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

248

911

1.98

21.11

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

+∞

21.05

6.2

0.0

1101.0

—

nmol/l

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

191

637

2.17

20.97

1.6

1.8

127.4

138.5

1.39

182

599

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

252

936

1.95

20.80

1.3

1.4

11.5

11.8

umol/l

0.39

239

913

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

200

3.19

20.54

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

593

2810

1.54

20.47

1.4

1.5

107.6

111.0

u/ml

0.37

120

651

(3010015) Selenium [Moles/volume] in Serum or Plasma

5.15

20.39

2.1

1.9

1.3

umol/l

0.30

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1029

1.90

20.38

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1029

1.90

20.38

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

267

1019

1.90

20.36

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

267

1019

1.90

20.36

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1030

1.90

20.32

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

267

1020

1.90

20.31

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

142

425

2.42

20.00

1.3

1.2

110.5

111.5

0.15

129

378

(3012494) Peanut IgE Ab [Units/volume] in Serum

139

413

2.44

19.88

1.1

1.6

6.7

u/ml

1.11

231

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

172

3.33

19.73

1.7

1.3

73.1

62.2

ng/l

0.16

124

(3006922) Hepatitis E virus Ab [Presence] in Serum

239

894

1.94

19.37

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

150

3.47

19.22

1.7

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

219

797

1.99

19.19

2.8

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

163

529

2.23

19.16

1.2

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

562

2672

1.53

19.14

1.9

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1020

5427

1.37

19.12

10.9

10.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

104

273

2.76

19.02

1.5

1.2

16.8

umol/l

0.02

249

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

162

528

2.22

18.86

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

252

970

1.89

18.78

1.5

1.3

1.4

nmol/l

0.01

227

879

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

463

2116

1.59

18.75

1.1

54.7

958.2

iu/ml

0.88

102

484

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

233

876

1.93

18.63

1.1

8.0

8.1

iu/ml

0.02

259

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

222

824

1.95

18.43

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

222

828

1.95

18.18

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

449

2055

1.59

18.09

1.5

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

143

450

2.30

18.08

1.1

118.1

109.0

1.88

133

400

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

265

1051

1.83

18.02

1.2

1.3

146.1

231.4

titre

1.08

177

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

264

1046

1.83

18.01

1.2

1.3

180.9

260.0

titre

0.26

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

134

412

2.36

17.86

1.2

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

134

412

2.36

17.86

1.2

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

634

3142

1.47

17.71

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2133

18625

0.81

17.69

2.6

0.6

0.7

ug/l

1.62

1368

10312

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

158

524

2.19

17.67

1.2

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

139

437

2.30

17.63

1.1

96.5

92.1

0.91

209

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

144

462

2.26

17.44

1.6

1.9

133.2

163.7

4.47

136

433

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

428

1957

1.59

17.34

1.0

0.6

0.4

u/ml

0.35

388

(40757494) Bilirubin.total [Moles/volume] in Blood

144

464

2.25

17.27

2.2

2.3

18.3

34.9

umol/l

0.71

(3023419) Bacteria identified in Sputum by Culture

279

1140

1.78

17.23

2.4

2.6

—

(3001556) Androgen free Index in Serum or Plasma

158

3.25

17.21

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

192

694

2.01

17.21

1.6

5.2

8.1

u/l

1.70

348

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

102

280

2.64

17.19

1.5

2.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

254

1010

1.82

17.15

6.2

4.6

7.1

mmol/l

0.01

204

816

(3025018) Bordetella pertussis Ab [Titer] in Serum

213

800

1.93

17.13

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

482

2277

1.54

16.95

1.2

3.1

3.7

u/ml

1.09

200

1059

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

388

1743

1.62

16.92

1.6

1.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

171

3.13

16.90

1.4

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

250

994

1.82

16.90

1.3

1.2

70.8

44.8

u/ml

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

103

287

2.60

16.88

2.2

3.0

28.0

28.2

umol/l

0.06

234

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

402

1824

1.60

16.83

1.6

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

508

2447

1.51

16.35

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

134

430

2.26

16.26

1.1

102.7

92.1

2.27

210

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

244

975

1.82

16.25

1.2

73.3

65.1

u/ml

0.15

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

142

3.31

16.23

1.4

1.2

0.4

0.3

nmol/l

0.50

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

473

2248

1.53

16.21

1.1

2.3

2.9

u/ml

0.96

209

1226

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

244

980

1.81

15.99

1.2

57.4

47.7

u/ml

0.22

(4146454)

246

991

1.80

15.97

2.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

162

566

2.07

15.94

1.6

1.7

1.6

1.2

nmol/l

2.44

117

465

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

254

2.65

15.87

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.85

15.19

1.2

—

(4094501)

657

3376

1.42

15.19

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

496

2416

1.49

15.17

1.6

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

510

2509

1.48

14.86

1.6

1.7

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

231

940

1.78

14.55

1.2

8.2

12.0

u/ml

0.23

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

389

1816

1.56

14.50

1.2

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

226

915

1.79

14.48

2.9

2.6

885.4

638.1

e6/l

4.90

381

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1366

7884

1.27

14.33

2.6

3.4

53.1

47.1

u/ml

0.10

1323

7648

(3049717) Cytology report of Urine Cyto stain

617

3170

1.42

14.30

2.2

2.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

160

583

1.99

14.12

2.0

—

(3011412) CD3 cells [#/volume] in Blood

280

1214

1.67

14.11

2.5

2.4

1.4

1.2

e9/l

2.28

158

716

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

480

2359

1.48

14.08

1.2

2.5

3.5

u/ml

1.13

149

853

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1460

12956

0.80

13.98

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

233

2.61

13.97

1.2

490.2

301.9

pmol/l

0.48

178

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

543

2745

1.44

13.78

1.2

1.3

3.0

3.9

ug/l

2.16

491

2479

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

118

388

2.20

13.60

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

217

887

1.77

13.51

2.7

2.6

558.3

506.7

e6/l

0.89

180

740

(3000475) Leukocytes [#/volume] in Synovial fluid

536

2716

1.43

13.44

1.5

1.7

14481.1

12148.3

e6/l

0.32

400

2010

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

290

1286

1.64

13.43

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

445

2180

1.48

13.29

1.1

124.7

118.3

3.61

402

1993

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

314

1424

1.60

13.29

1.6

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

144

517

2.02

13.27

1.9

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

146

3.02

13.25

1.4

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1026

5780

1.29

13.07

1.5

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

111

363

2.21

12.99

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

207

846

1.77

12.92

4.2

4.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

459

2277

1.46

12.89

1.1

—

(3047181) Lactate [Moles/volume] in Blood

611

3193

1.39

12.89

6.6

5.6

1.3

1.2

mmol/l

0.20

544

2811

(3030313) Adrenal Ab [Titer] in Serum

122

3.20

12.88

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

327

1510

1.57

12.85

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

198

2.67

12.72

1.3

1.4

67.6

55.8

mu/l

0.26

149

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3855

31183

0.87

12.47

4.1

4.0

1.7

2.4

ug/l

3.51

3444

28839

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

825

4544

1.32

12.42

1.7

1.6

0.8

5.0

iu/ml

0.58

155

923

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

114

3.24

12.39

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

252

1102

1.66

12.36

1.5

2.0

—

(4306422)

454

2267

1.45

12.35

1.2

—

(3045716) Anion gap in Serum or Plasma

111

371

2.17

12.35

2.6

2.5

9.4

8.8

mmol/l

0.76

263

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

208

865

1.74

12.26

2.7

0.2

e9/l

0.03

178

741

(3008116) Ketones [Moles/volume] in Urine by Test strip

165

2.81

12.26

1.6

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

284

1283

1.61

12.26

3.3

5.3

110.2

121.5

u/ml

0.09

456

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

173

681

1.84

12.23

1.2

1.3

99.2

83.2

u/l

0.70

150

605

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

735

3991

1.34

12.20

5.9

4.9

1.9

1.6

4.81

698

3737

(3033923) Metanephrine [Moles/time] in 24 hour Urine

199

2.62

12.12

1.1

0.7

umol/24h

0.66

106

(3001964) Herpes simplex virus Ag [Presence] in Specimen

113

384

2.13

12.07

1.7

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

168

659

1.85

12.02

1.2

1.3

28.7

21.1

u/l

0.71

145

575

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

277

1251

1.61

11.98

8.2

6.6

11.3

11.0

mg/l

0.45

258

1174

(3020491) Glucose [Moles/volume] in Blood

228

980

1.69

11.96

1.7

1.6

6.9

6.3

mmol/l

2.03

176

712

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

113

3.20

11.95

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

236

2.45

11.82

1.1

2.0

6.3

u/ml

1.08

168

(3023420) DNA double strand Ab [Units/volume] in Serum

333

1577

1.53

11.75

1.6

40.0

37.1

iu/ml

0.07

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

153

591

1.88

11.50

1.2

1.1

25.8

21.3

u/l

0.35

115

478

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

244

2.40

11.47

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

492

2531

1.41

11.42

2.4

2.6

96.7

97.4

ug/min

0.01

305

1639

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

212

907

1.69

11.34

2.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

241

2.40

11.33

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

228

2.44

11.31

1.0

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

216

2.48

11.21

1.1

1.2

0.2

1.7

u/ml

0.78

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

152

592

1.86

11.16

1.2

1.1

89.8

83.0

u/l

0.33

122

491

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

243

2.38

11.14

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

111

3.13

11.09

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

248

2.36

11.09

1.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

183

2.61

11.08

1.0

74.6

81.6

ug/l

0.65

152

(3007930) Methemoglobin/Hemoglobin.total in Blood

712

3910

1.32

10.99

6.0

5.0

0.9

0.69

679

3667

(4034850)

707

3880

1.33

10.96

10.0

7.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

121

440

1.99

10.87

1.1

3000.3

467.7

ng/l

0.48

124

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

282

1312

1.56

10.81

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

292

1371

1.54

10.76

1.7

1.6

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

23.13

10.60

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

206

894

1.67

10.49

2.1

2.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

525

2776

1.37

10.41

6.1

6.5

1803.1

1458.8

iu/ml

0.14

446

(3002619) Bacteria identified in Specimen by Culture

194

2.50

10.35

1.2

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

120

2.95

10.33

1.0

0.1

1.3

u/ml

0.74

(3008757) Leukocyte morphology finding [Identifier] in Blood

237

1071

1.60

10.30

2.6

3.8

—

(21494815) CD4 cells/100 lymphocytes in Specimen

249

1141

1.58

10.22

2.0

2.1

47.0

40.2

1.72

157

(3051611) Lipemic interference index of Serum or Plasma

245

1119

1.59

10.20

3.3

3.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

220

979

1.63

10.18

2.1

2.0

77.0

73.2

4.90

208

950

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

118

436

1.96

10.17

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

286

2.20

10.16

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

407

2069

1.43

10.15

3.0

264.3

4293.3

u/ml

0.92

101

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

555

2975

1.36

10.11

1.3

1.5

—

(3045424) Erythrocytes [Presence] in Urine

416

2125

1.42

10.11

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

19.27

10.09

1.0

—

mmol/l

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

210

2.41

10.06

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

131

504

1.88

10.04

1.2

49.2

98.9

titre

0.67

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

130

502

1.88

9.86

1.1

1.0

8.8

13.6

u/ml

0.64

(3042631) Mycobacterium sp identified in Specimen

251

1167

1.56

9.71

2.6

2.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.94

9.70

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

146

2.68

9.57

1.0

0.1

0.2

u/ml

0.42

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.34

9.53

2.2

2.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

227

1036

1.59

9.52

1.0

1.1

0.5

1.3

u/ml

1.22

278

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.62

9.51

1.2

1.6

36.2

30.2

0.26

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

221

1006

1.59

9.37

1.5

2.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

205

919

1.62

9.26

1.1

1.2

1.0

1.1

ratio

0.63

323

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

607

3343

1.32

9.25

3.4

3.3

1.4

mg/l

0.08

552

3121

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

285

2.13

9.13

1.1

1.2

90.3

88.8

0.09

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

213

970

1.59

9.04

2.1

2.0

12.3

14.1

1.53

111

458

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

196

875

1.62

9.02

1.4

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

196

875

1.62

9.02

1.4

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

196

875

1.62

9.02

1.4

1.9

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

160

677

1.71

9.02

1.2

14.9

18.9

u/ml

0.12

(3051651) Icteric interference index of Serum or Plasma

152

635

1.73

8.97

3.6

3.5

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

302

2.08

8.94

1.1

1.3

108.1

104.9

0.45

281

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

564

3090

1.33

8.93

3.7

3.6

0.3

u/ml

0.18

322

1729

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

3.12

8.83

1.0

0.0

0.3

u/ml

0.94

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

104

2.92

8.74

1.5

2.4

1.4

mg/l

0.86

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

104

2.92

8.74

1.5

3.4

1.6

mg/l

0.92

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

104

2.92

8.74

1.5

2.0

mg/l

0.01

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

104

2.92

8.74

1.5

3.4

2.7

mg/l

0.21

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

104

2.92

8.74

1.5

1.3

1.6

mg/l

0.19

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

104

2.92

8.74

1.5

3.3

1.5

mg/l

0.81

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

104

2.92

8.74

1.5

3.8

4.5

mg/l

0.27

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

104

2.92

8.74

1.5

1.0

0.8

mg/l

0.14

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

104

2.92

8.74

1.5

3.0

3.3

mg/l

0.08

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

108

2.88

8.74

1.5

2.2

1.9

mg/l

0.13

(3000060) B lymphocytes [#/volume] in Blood

100

370

1.96

8.66

2.6

1.9

136.1

234.8

e6/l

0.84

176

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

105

2.89

8.61

2.4

3.1

1.2

1.1

mmol/l

0.05

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

246

1173

1.52

8.56

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

140

580

1.75

8.53

1.3

1.5

18.3

23.3

u/ml

0.61

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

242

1151

1.52

8.52

1.7

—

(3044941) Cell count panel - Synovial fluid

341

1738

1.42

8.48

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

106

2.87

8.47

2.0

1.9

—

(3003694) ABO and Rh group [Type] in Blood

6610

44631

1.09

8.45

1.5

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

219

1021

1.55

8.44

1.2

1.5

87669.9

72156.6

e6/l

0.16

156

679

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

423

2239

1.37

8.43

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

206

2.28

8.35

2.9

2.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

291

2.06

8.34

1.1

1.2

80.5

76.8

0.20

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

5.42

8.31

1.0

0.0

0.2

u/ml

—

(3006245) CD3-CD19+ cells/100 cells in Blood

124

501

1.79

8.23

2.4

2.1

8.4

10.2

1.62

116

467

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

165

724

1.65

8.18

1.4

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

155

669

1.68

8.18

1.0

1.1

100.5

95.8

1.05

120

538

(4015189)

213

2.24

8.15

2.3

1.9

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.44

8.11

1.1

1.6

13.6

15.3

0.10

(3017569) Oxygen content in Arterial blood

364

1.93

8.10

1.9

2.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

126

2.64

8.02

1.0

0.1

1.8

u/ml

0.51

(3035947) Staphylolysin Ab [Units/volume] in Serum

132

549

1.74

7.97

1.2

1.1

3.2

3.9

iu/ml

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

131

2.59

7.93

1.0

1.4

56.2

60.9

0.21

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

4.66

7.92

1.0

0.4

1.0

u/ml

0.50

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

3.11

7.89

1.0

0.3

1.4

u/ml

0.70

(3000330) Specific gravity of Urine by Test strip

953

5658

1.23

7.88

3.3

2.9

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

171

766

1.62

7.83

2.5

3.5

102.5

133.4

nmol/l

0.66

164

755

(3016031) Almond IgE Ab [Units/volume] in Serum

2.96

7.70

1.0

1.1

0.2

0.4

u/ml

0.48

(3004451) EKG impression Narrative

104

407

1.85

7.68

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

171

772

1.60

7.61

1.3

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

329

1704

1.40

7.53

2.6

3.1

275.3

345.0

u/ml

0.11

316

1590

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

109

436

1.81

7.52

2.4

2.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

117

479

1.77

7.48

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

314

1617

1.41

7.43

1.1

97.9

96.1

0.54

298

1532

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

636

3640

1.27

7.33

1.4

98.0

121.6

pmol/l

0.98

622

3558

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.02

7.32

1.1

16.8

14.0

nmol/l

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

133

569

1.69

7.30

1.2

1.1

—

(4268621)

311

1605

1.40

7.28

2.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

213

1022

1.51

7.28

1.1

1.0

2.7

2.8

u/ml

0.02

249

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

6.71

7.24

1.1

1.5

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

3.11

7.23

1.0

9.4

20.7

u/ml

0.99

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

258

1290

1.45

7.19

2.5

3.3

4.7

8.9

nmol/l

0.47

246

1247

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

230

2.11

7.17

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

118

492

1.74

7.11

2.4

2.0

28.5

30.2

0.69

111

469

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

226

2.11

7.11

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

236

2.08

7.08

1.3

1.2

—

(3010503) CD19 cells [#/volume] in Blood

163

745

1.58

6.94

2.5

2.6

0.2

0.4

e9/l

1.34

155

732

(3034860) Kappa light chains.free [Mass/volume] in Serum

487

2715

1.30

6.92

2.9

3.6

41.3

49.4

mg/l

1.24

385

2244

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

136

595

1.65

6.90

2.3

2.6

24.4

277.7

ug/l

1.46

127

567

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

104

422

1.78

6.89

1.4

2.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

104

422

1.78

6.89

1.4

2.6

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.48

6.89

1.0

1.4

0.6

1.7

1.06

(3044242) Glucose [Moles/volume] in Arterial blood

375

1.83

6.88

2.3

2.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

474

2635

1.31

6.88

2.8

3.5

1.9

ratio

0.06

217

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

107

439

1.76

6.84

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

485

2711

1.30

6.77

3.0

3.6

28.1

45.4

mg/l

2.83

384

2238

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

105

430

1.77

6.76

1.4

2.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

117

2.53

6.66

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

194

2.16

6.65

1.1

0.1

u/ml

0.06

136

(3051593) INR in Capillary blood by Coagulation assay

303

1.91

6.59

4.8

13.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

241

1211

1.44

6.59

1.5

1.3

159.6

171.1

pmol/l

0.03

110

285

(3028433) Virus identified in Specimen by Culture

366

1.82

6.53

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

141

2.36

6.46

1.0

0.1

0.3

u/ml

0.79

(3002523) Influenza virus A Ag [Presence] in Specimen

508

2878

1.28

6.41

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

146

2.33

6.41

1.0

0.3

6.9

u/ml

0.92

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.82

6.37

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

364

1.81

6.36

1.7

1.6

8.4

8.7

ug/l

0.37

364

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

302

1.89

6.35

1.0

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

116

499

1.68

6.31

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

201

984

1.48

6.30

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

220

1098

1.45

6.26

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

384

2106

1.32

6.19

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

388

2133

1.32

6.16

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

116

503

1.67

6.14

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

140

2.32

6.13

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

505

2877

1.27

6.12

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

162

763

1.54

6.11

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

164

776

1.53

6.06

1.6

1.7

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

119

2.43

6.01

1.0

—

(44806071)

175

2.15

5.92

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

261

1361

1.39

5.85

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

132

601

1.59

5.79

1.5

2.7

2.9

u/field

0.13

438

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

108

2.48

5.79

1.1

1.6

1.7

umol/24h

0.19

108

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

571

1.60

5.65

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.81

5.57

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

285

1.85

5.56

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

285

1.85

5.56

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

285

1.85

5.56

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

285

1.85

5.56

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

162

1716

0.68

5.53

1.2

—

(3019977) pH of Arterial blood

106

463

1.66

5.51

2.8

2.3

7.4

0.14

164

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

138

2.25

5.50

1.0

0.1

0.5

u/ml

0.83

(3021788) Differential panel - Synovial fluid

376

2095

1.30

5.47

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

162

2.14

5.46

1.9

1.7

130.2

42.0

pmol/l

0.45

142

(40768441) Liver Pathology biopsy report

188

939

1.45

5.40

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

299

1616

1.34

5.39

1.2

1.3

26.5

30.9

u/l

0.30

258

1421

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

107

472

1.64

5.36

1.1

—

(4024509)

202

1024

1.43

5.36

1.7

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

397

1.69

5.28

3.1

3.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

105

464

1.64

5.24

3.4

3.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.70

5.21

1.0

1.1

117.7

85.0

nmol/24h

0.49

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.80

5.17

1.2

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

154

746

1.49

5.17

3.3

2.8

44.9

37.4

2.83

257

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

123

567

1.57

5.17

1.4

2.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

2.43

5.17

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

316

1736

1.32

5.12

2.4

3.4

1.3

1.5

0.72

244

1383

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.85

5.11

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.52

5.09

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.16

5.09

1.4

1.7

45.2

48.1

umol/l

0.16

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

310

1.77

5.07

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

146

704

1.50

5.03

1.1

1679.0

1400.7

miu/ml

1.92

146

704

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

311

1.77

5.02

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

311

1.77

5.02

1.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

122

566

1.56

5.01

1.4

2.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

122

566

1.56

5.01

1.4

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

122

566

1.56

5.01

1.4

2.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

130

2.22

5.01

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

249

1.86

4.97

3.2

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

249

1.86

4.97

3.2

2.2

—

(3024263) Appearance of Synovial fluid

124

580

1.55

4.92

1.8

1.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

200

1031

1.40

4.88

2.3

3.5

57.8

0.00

131

690

(3005082) Progesterone [Moles/volume] in Serum or Plasma

216

1131

1.38

4.81

1.3

1.4

28.2

32.7

nmol/l

1.52

192

1061

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

796

6742

0.85

4.80

1.9

1.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

232

1.87

4.76

1.3

1.6

0.4

ug/l

0.00

155

(3005011) Chlamydia sp Ab [Titer] in Serum

164

2.03

4.61

1.6

1.4

—

(3037756) Immunofixation for Serum or Plasma

321

1796

1.29

4.60

1.5

1.9

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

169

2.01

4.60

1.4

1.5

545168.1

336191.5

nmol/l

0.21

152

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

+∞

4.58

1.0

0.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

241

1.83

4.55

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

386

2214

1.26

4.55

1.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.92

4.50

1.1

0.5

1.0

umol/24h

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

663

0.54

4.49

3.5

3.2

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

127

611

1.50

4.47

1.4

1.9

182.9

202.2

u/l

3.91

127

606

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

662

0.54

4.47

6.9

6.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

192

1.92

4.41

1.5

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

162

2.01

4.41

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

281

1.75

4.40

1.8

1.7

—

(1761868) Lipid panel - Serum or Plasma

8032

60373

0.94

4.38

2.6

2.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.23

4.29

1.0

—

(4211845)

131

641

1.48

4.27

2.8

2.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

102

2.27

4.24

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

160

1.99

4.21

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

171

1.94

4.15

1.1

—

(44790048)

232

1261

1.33

4.14

1.8

1.6

—

(44790049)

232

1261

1.33

4.14

1.8

1.6

—

(44790047)

232

1261

1.33

4.14

1.8

1.6

—

(44806118)

232

1261

1.33

4.14

1.8

1.6

—

(3006462) Nitrate [Presence] in Urine

120

581

1.49

4.13

2.9

2.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

109

519

1.52

4.07

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

189

1001

1.37

4.01

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

172

899

1.38

3.96

1.8

1.3

59.8

72.3

umol/l

—

102

(3015076) Soybean IgE Ab [Units/volume] in Serum

179

945

1.37

3.89

1.0

0.3

0.4

u/ml

0.44

122

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

433

1.55

3.86

2.4

1.6

475.8

28205.5

u/ml

0.74

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

102

485

1.52

3.85

2.4

2.0

83.8

64.1

ug/min

0.16

105

(3036603) Volume of Urine

156

806

1.40

3.85

1.4

1.8

1752.5

1889.2

0.40

185

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.80

3.83

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

158

820

1.39

3.81

1.7

2.1

1.4

1.1

g/24h

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

215

1172

1.33

3.80

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

124

616

1.46

3.80

2.3

2.5

154.7

138.6

au/ml

0.13

(3039000) Anion gap in Blood

377

2207

1.24

3.79

8.8

6.8

11.4

11.1

mmol/l

0.88

346

1981

(3018572) Chloride [Moles/volume] in Blood

377

2208

1.24

3.78

8.8

6.8

104.7

105.5

mmol/l

2.33

346

1982

(3025296) Carrot IgE Ab [Units/volume] in Serum

3.77

3.75

1.0

4.4

0.4

u/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

113

554

1.48

3.71

1.1

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

347

1.60

3.68

2.3

1.8

8585.1

3824.3

e6/l

0.31

233

(3002331) Protein [Mass/volume] in Peritoneal fluid

195

1.82

3.65

1.3

25.2

28.7

g/l

0.75

158

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

100

2.17

3.62

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

317

1832

1.25

3.60

1.2

—

(3000012) Reticulocyte production index

102

494

1.49

3.57

1.2

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

306

1.63

3.53

1.1

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

192

1042

1.33

3.53

1.4

1.6

37.8

34.0

0.68

118

663

(40768793) Breast Pathology biopsy report

519

3163

1.19

3.50

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

162

858

1.37

3.49

1.8

1.7

2.4

2.0

u/field

0.35

388

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.35

3.48

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

520

3173

1.19

3.46

1.3

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

157

1.89

3.45

2.6

2.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

351

2063

1.23

3.44

3.0

3.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

358

3152

0.82

3.43

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

148

1.90

3.38

1.5

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

471

1.49

3.37

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

310

1.61

3.37

2.3

1.7

18459.9

15126.5

e6/l

0.09

159

(3002079) Sodium [Moles/time] in 24 hour Urine

5.42

3.37

1.1

1.2

151.6

127.9

mmol/24h

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

334

1960

1.23

3.34

2.4

2.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.61

3.26

1.1

3.3

3.8

2.2

mu/l

0.33

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

662

5504

0.87

3.26

1.7

1.8

—

(3016228) CD19 cells/100 cells in Blood

102

505

1.46

3.24

1.7

2.0

7.9

8.8

0.44

497

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.14

3.21

1.0

7.7

9.8

u/ml

0.24

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.41

3.08

1.5

0.9

0.6

umol/l

0.67

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

129

676

1.38

3.03

2.9

3.0

8.3

8.0

mg/l

0.19

551

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

547

4583

0.86

3.02

1.4

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

351

2097

1.21

2.99

3.2

2.6

1.5

mmol/l

0.00

343

2051

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

151

814

1.34

2.97

2.2

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

100

505

1.43

2.91

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

110

1.97

2.90

1.0

1.1

—

(3016750) Collection duration of Urine

122

639

1.38

2.89

2.1

2.3

511.7

493.8

min

1.45

516

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.19

2.89

1.0

1.1

8.7

12.5

u/l

0.46

(3013166) Neutrophils/100 leukocytes in Synovial fluid

325

1.54

2.83

1.2

1.5

37.7

52.4

2.50

278

(3042628) Porphyrins [Moles/volume] in Urine

7.22

2.81

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

153

1.80

2.80

6.1

7.3

66.5

74.0

0.96

121

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

131

698

1.36

2.80

7.7

5.4

311.0

872.0

u/ml

0.66

123

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

384

1.49

2.80

3.7

4.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

497

1.43

2.80

1.7

2.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

112

1.94

2.77

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

145

787

1.33

2.76

2.1

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

380

1.48

2.74

1.6

1.8

—

(3000285) Sodium [Moles/volume] in Blood

123

1.88

2.73

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

150

820

1.32

2.72

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

1.99

2.70

1.1

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

119

1.88

2.66

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

503

1.41

2.64

3.7

8.2

2211.7

4004.6

mg/l

0.33

362

(3026250) Tacrolimus [Mass/volume] in Blood

132

713

1.34

2.61

39.2

35.8

7.6

7.4

ug/l

0.34

120

656

(3002814) Trichinella spiralis Ab [Titer] in Serum

5.06

2.60

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

6.19

2.59

1.2

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.08

2.58

1.4

1.3

323.6

321.0

umol/24h

0.02

(3026692) Albumin [Mass/volume] in Peritoneal fluid

218

1.62

2.57

1.8

1.2

11.0

14.6

g/l

1.77

180

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

163

1.73

2.57

2.4

2.5

7.1

7.7

mmol/l

0.35

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1695

11354

1.08

2.54

3.3

4.4

13.9

27.4

ug/l

1.83

1305

8817

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

203

1.64

2.50

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

177

1003

1.28

2.50

3.0

2.9

24.6

63.0

mg/l

3.02

122

705

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

216

1926

0.81

2.46

1.4

1.6

8.0

7.4

mmol/l

2.34

146

1118

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

315

1.49

2.39

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

101

986

0.74

2.37

1.2

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

219

1.58

2.31

2.5

2.7

28.6

46.5

mg/l

0.53

(3015350) Toxocara sp Ab [Presence] in Serum

4.21

2.28

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

2.02

2.23

1.0

1.1

0.8

22.4

u/ml

0.48

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

374

1.43

2.23

1.4

1.8

—

547.0

iu/ml

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

111

1.82

2.23

1.2

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

199

1.60

2.21

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

188

1.61

2.20

2.2

2.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

117

641

1.32

2.17

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

419

1.40

2.16

2.0

1.5

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.10

2.12

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.10

2.12

1.1

1.0

—

(3017704) Immunofixation for Urine

476

1.37

2.11

1.4

1.8

—

(3009677) Dengue virus Ab [Presence] in Serum

2.05

2.10

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.01

2.10

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

157

1.66

2.10

1.0

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

244

1471

1.20

2.02

1.5

1.6

56.0

54.2

0.26

152

988

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.48

2.01

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.03

1.96

1.1

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

224

1.52

1.93

1.7

2.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.87

1.92

2.0

1.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.87

1.92

1.0

1.1

0.1

0.9

u/ml

0.90

(3010838) Calcium [Moles/time] in 24 hour Urine

104

572

1.31

1.92

1.7

1.6

5.2

5.4

mmol/24h

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

3.94

1.92

1.5

1.0

—

27.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

535

1.32

1.91

1.2

—

(3044007) Cell count panel - Peritoneal fluid

285

1.45

1.87

2.2

1.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.93

1.83

1.3

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

108

1.74

1.83

1.0

0.1

1.7

u/ml

0.57

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

257

1.46

1.82

1.1

—

(3034614) HLA Ag [Interpretation]

2.34

1.81

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.89

1.80

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

114

642

1.28

1.79

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

131

1.65

1.78

1.2

1.3

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

178

1.54

1.71

1.9

2.4

25.8

23.0

mg/l

0.52

164

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.75

1.71

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.91

1.70

1.1

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

196

1.51

1.69

2.8

2.1

—

(44806420)

214

1.49

1.68

1.9

2.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

432

2770

1.13

1.66

3.5

2.8

25.1

26.3

mg/l

0.20

233

1779

(3004775) Volume in Urine collected for unspecified duration

146

856

1.23

1.66

2.2

2.4

707.9

669.9

0.44

114

627

(3036670) Protein [Mass/volume] in Synovial fluid

299

1.40

1.65

1.3

39.8

41.4

g/l

0.42

163

(3042733) HLA Ab [Presence] in Serum

542

1.29

1.64

4.4

5.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.88

1.63

1.1

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.92

1.62

1.4

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.13

1.62

1.7

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

387

2470

1.13

1.61

1.3

1.4

6.9

mmol/l

0.10

288

1783

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.01

1.61

1.6

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

113

646

1.26

1.61

28.4

26.9

112.5

119.5

ug/l

0.56

536

(3037556) Urate [Mass/volume] in Serum or Plasma

295

1.40

1.60

1.2

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

113

1.66

1.59

1.5

2.6

—

(40762887) Creatinine [Moles/volume] in Blood

2.81

1.59

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.10

1.56

6.5

2.8

—

(3034426) Prothrombin time (PT)

534

1.29

1.56

1.1

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.93

1.55

1.3

1.4

—

23.4

—

(3019174) dRVVT (LA screen)

126

1.61

1.52

1.3

—

(3012565) Volume of 24 hour Urine

102

581

1.27

1.51

1.7

2.3

1907.0

2011.4

0.49

531

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.76

1.50

1.3

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

232

1.43

1.50

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

417

1.32

1.50

1.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.04

1.47

1.3

1.5

1.4

0.75

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

215

1.45

1.47

1.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.89

1.46

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

313

1.36

1.45

1.7

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

204

1.45

1.44

5.0

5.3

59.2

41.3

ug/min

0.52

163

(3038515) Glucose [Moles/volume] in Venous blood

314

1996

1.14

1.43

3.5

2.7

7.1

7.4

mmol/l

0.83

306

1959

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.26

1.42

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

211

1.44

1.41

2.2

1.7

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.15

1.40

1.1

1.0

0.1

u/ml

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

164

993

1.19

1.40

1.3

1.4

5.7

5.4

mmol/l

1.34

155

946

(3050794) Legionella sp Ab [Presence] in Serum

101

1.65

1.38

1.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

1.37

0.0

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

341

2187

1.13

1.37

2.9

3.8

765.2

667.2

u/ml

0.09

306

2004

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.71

1.37

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

619

4098

1.09

1.37

3.2

3.9

334.1

2109.5

u/ml

1.78

520

3537

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.96

1.33

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

108

1.61

1.33

1.2

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.17

1.32

1.6

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

114

671

1.23

1.31

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

570

0.76

1.31

1.2

1.3

14.2

14.5

u/l

0.06

523

(3035285) Chloride [Moles/volume] in Venous blood

182

1122

1.17

1.29

2.5

2.0

105.9

105.6

mmol/l

0.34

182

1110

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.55

1.28

3.2

5.7

—

(3041354) Potassium [Moles/volume] in Venous blood

182

1124

1.17

1.27

2.5

2.0

4.0

mmol/l

0.21

182

1112

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

174

1.45

1.26

2.1

2.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

104

1.60

1.26

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

143

1226

0.84

1.25

1.2

1.3

1.5

g/l

0.05

(3033705) Calcium.ionized [Moles/volume] in Venous blood

179

1107

1.17

1.23

2.5

2.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.78

1.23

1.8

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

105

0.48

1.23

1.1

1.4

62.4

69.4

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.61

1.23

1.3

3.0

2.2

656.9

pmol/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.61

1.23

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

180

1119

1.16

1.18

1.8

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

766

5161

1.07

1.15

1.4

1.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.06

1.14

1.1

1.3

1.9

2.2

mmol/24h

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

214

0.64

1.12

7.8

7.6

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.62

1.10

1.3

1.1

11.9

4.9

u/ml

0.25

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

485

1.24

1.07

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

485

1.24

1.07

1.4

1.5

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

199

1.38

1.07

1.7

1.4

1.8

mg/l

0.90

166

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.64

1.05

1.2

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

198

1254

1.14

1.04

3.2

2.8

0.8

nmol/l

1.14

138

956

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.69

1.04

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

770

5926

0.94

1.02

1.4

1.6

—

(3022475) Manganese [Moles/volume] in Blood

1.55

1.01

1.0

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.71

1.01

3.5

2.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

407

2690

1.09

1.01

4.6

3.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.62

1.00

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

1.00

0.0

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

1.00

0.0

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.90

0.98

6.3

5.1

0.2

mmol/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

181

1146

1.14

0.97

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

133

823

1.17

0.97

1.2

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.60

0.96

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.95

0.95

6.1

9.4

—

(40768446) Kidney Pathology biopsy report

592

1.20

0.95

1.8

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

746

5066

1.07

0.94

1.4

1.5

—

(3022229) Phosphate [Moles/volume] in Urine

1.71

0.93

1.2

1.8

12.1

19.9

mmol/l

2.51

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

246

1594

1.12

0.92

1.4

12.5

11.7

mmol/l

0.57

280

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.17

0.91

1.5

2.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.54

0.90

5.1

2.0

—

(3010937) Rubella virus Ab [Presence] in Serum

114

1.46

0.90

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1047

7945

0.95

0.89

1.4

—

(3029612) Listeria sp Ab [Titer] in Serum

1.86

0.87

1.5

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

115

1.45

0.87

1.2

1.3

5.0

6.2

mmol/l

0.61

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.59

0.86

1.0

0.2

0.1

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

388

1.23

0.86

1.5

1.4

—

(3005033) Fetal Nuchal fold Thickness US

741

5051

1.06

0.85

1.4

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.56

0.85

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

103

0.56

0.84

1.3

1.5

—

(40758292) HTLV I+II Ab panel - Serum

265

0.74

0.82

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.88

0.81

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

557

1.18

0.80

1.3

1.5

6.6

4.5

0.38

136

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.58

0.78

1.1

1.3

20.8

21.7

mmol/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

161

1.35

0.78

9.7

9.3

5.4

5.6

mmol/l

0.11

161

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

488

0.81

0.78

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

250

1.27

0.78

3.0

2.7

—

(3035880) pH of Pleural fluid

432

0.80

0.78

1.4

1.3

—

(4281824)

196

1572

0.90

0.75

1.1

—

(3045142) Bone marrow Pathology biopsy report

152

1237

0.89

0.75

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

103

641

1.16

0.75

2.1

1.9

8.1

9.9

mg/l

3.13

522

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

301

0.77

0.75

11.0

8.3

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.01

0.72

1.2

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.01

0.72

1.2

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

279

1.24

0.72

5.2

5.4

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

167

0.69

0.71

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

217

0.73

0.71

3.9

1.2

7.5

7.1

mmol/l

0.18

(3013293) Extractable nuclear Ab [Presence] in Serum

215

1.28

0.71

1.4

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

274

0.76

0.71

11.4

8.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

431

3327

0.93

0.70

1.6

1.7

—

(4212803)

1.46

0.70

1.2

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.62

0.69

11.6

9.2

—

(3015183) Erythrocyte sedimentation rate

129

823

1.13

0.69

1.3

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.46

0.67

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

901

6230

1.05

0.66

1.4

1.5

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

1.81

0.66

1.2

1.9

mg/l

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

245

1.24

0.63

3.0

5.8

69.2

58.4

u/l

0.16

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

899

6224

1.04

0.63

1.4

1.5

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

1.72

0.63

1.0

58.6

37.5

—

(3046861) Legionella sp Ag [Presence] in Urine

1.52

0.60

1.2

1.0

—

(3022670) pH of Venous cord blood

1.81

0.59

1.0

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.81

0.59

1.0

1.1

66.7

71.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

121

979

0.89

0.59

1.4

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

307

1.20

0.59

1.9

1.8

30.2

30.0

u/l

0.00

282

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

115

739

1.12

0.58

1.2

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.40

0.58

3.3

2.7

22.6

10.3

—

(3020650) Glucose [Presence] in Urine

401

1.17

0.57

1.4

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

896

6222

1.04

0.57

1.3

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.43

0.57

2.5

5.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

892

6199

1.04

0.55

1.3

1.5

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.50

0.52

1.0

0.0

0.1

u/ml

—

(3048879) Bone marrow aspiration report

278

1.20

0.52

1.6

2.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

1.36

0.52

1.1

1.3

34.8

22.2

0.49

(40768806) Pleura Pathology biopsy report

105

846

0.90

0.50

1.6

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

219

0.79

0.49

5.1

4.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.53

0.48

1.0

1.1

—

(3016135) IgD [Mass/volume] in Serum

1.53

0.48

1.0

2.5

37.7

171.1

mg/l

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.37

0.48

2.9

5.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

323

1.16

0.45

1.3

48.3

40.0

0.83

231

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.44

0.45

1.1

129.6

118.8

ug/l

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.35

0.45

1.0

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

1.33

0.43

1.1

1.0

—

2.7

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

352

1.15

0.43

1.4

2.5

94.9

101.5

ng/l

0.13

181

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.62

0.42

1.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

113

1.28

0.42

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.42

0.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1616

11938

0.98

0.41

1.4

1.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.50

0.41

1.0

1.1

2.0

3.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.40

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.38

0.39

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.33

0.39

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

135

1055

0.92

0.38

1.5

1.4

35.2

34.8

g/l

0.14

124

965

(40768795) Lymph node Pathology biopsy report

176

1361

0.93

0.38

1.2

—

(3006598) pH of Arterial cord blood

1.39

0.38

1.0

1.1

—

(4035726)

1581

11180

1.02

0.37

1.4

—

(3024932) HLA-DR beta [Type]

535

1.11

0.37

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

134

896

1.08

0.37

5.8

6.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.49

0.36

1.2

1.0

—

(3013762) Body weight Measured

1.37

0.36

1.0

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

497

1.10

0.34

1.8

1.6

130.7

122.2

au/ml

0.05

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.30

0.34

1.0

1.1

—

(3024471) HLA-A [Type]

546

1.10

0.33

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

160

0.81

0.33

3.0

3.2

—

(3047189) Immunofixation for 24 hour Urine

437

0.89

0.33

1.9

2.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.37

0.31

1.0

1.3

—

(4133840)

526

0.91

0.31

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

143

0.81

0.31

1.2

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.30

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

100

668

1.08

0.30

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

119

802

1.07

0.29

1.3

6.5

6.2

mmol/l

0.44

107

747

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.27

0.26

1.1

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

595

0.92

0.26

1.7

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

116

0.81

0.26

1.1

—

(21494434) Karyotype in Bone marrow

118

907

0.94

0.26

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

244

1.13

0.25

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

120

815

1.06

0.25

1.6

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.20

0.25

19.3

10.9

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.18

0.24

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

218

1.13

0.24

1.4

1.2

70.1

53.3

mg/l

0.08

150

(3018291) Platelet Ab [Presence] in Serum

1.29

0.23

1.0

—

(40760410) HLA-B [Type] by High resolution

0.75

0.23

1.0

—

(40763590) HLA-DQ beta [Type]

0.75

0.23

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.75

0.23

1.0

—

(40760409) HLA-A [Type] by High resolution

0.75

0.23

1.0

—

(3013862) HLA-DP [Type]

0.73

0.22

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

168

0.86

0.22

6.1

5.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.25

0.22

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.25

0.22

2.4

2.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.25

0.22

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.22

0.0

1.4

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.22

0.0

1.1

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.20

0.22

1.4

2.8

0.1

ug/l

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

121

0.84

0.21

1.1

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.22

0.21

1.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40762814) Titanium [Mass/volume] in Blood

174

0.87

0.20

2.8

2.4

3.9

5.3

ug/l

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.23

0.18

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

233

1740

0.97

0.18

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

938

6671

1.02

0.18

1.4

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

125

864

1.05

0.17

1.6

1.8

3.5

mg/l

0.00

117

832

(40758358) Immune stain study

1.20

0.16

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

1.15

0.16

1.1

—

(3001729) Color of Synovial fluid

1.16

0.15

1.3

1.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.10

0.15

1.0

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

711

0.95

0.15

1.3

830.9

426.8

u/l

0.73

678

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.82

0.13

1.1

1.2

—

(4038314)

190

0.91

0.13

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

663

0.96

0.12

2.5

3.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

489

1.05

0.12

2.3

3.8

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

221

1.08

0.12

1.2

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

180

1.08

0.11

1.1

1.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.14

0.10

2.3

1.8

67.2

63.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

104

1.11

0.10

1.2

—

(3025315) Body weight

104

1.11

0.10

3.1

3.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

111

1.11

0.10

1.4

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.09

0.10

1.0

1.1

243.0

292.9

nmol/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

128

950

0.97

0.09

2.1

2.3

—

(3026470) Cobalt [Mass/volume] in Blood

584

0.96

0.09

2.2

2.1

2.2

4.0

ug/l

3.19

524

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.11

0.09

1.2

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.08

0.09

3.7

3.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.06

0.08

1.3

1.6

—

(3045788) Cell count panel - Pleural fluid

101

751

0.97

0.08

1.6

1.5

—

(3014891) Appearance of Pleural fluid

1.11

0.08

1.6

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

190

1.06

0.08

1.1

1.4

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.83

0.08

1.0

36.2

36.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

163

0.93

0.07

1.5

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.07

0.07

2.0

1.3

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

1.07

0.07

1.0

1.5

—

562.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

212

1.06

0.07

1.1

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.08

0.07

1.8

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.07

0.07

1.7

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.03

0.07

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

326

2326

1.01

0.07

3.9

3.5

24.2

36.3

u/ml

2.38

313

2236

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

103

0.91

0.06

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

239

1703

1.01

0.06

1.6

1.7

—

(3026726) Creatinine [Moles/volume] in Specimen

100

1.08

0.05

2.0

2.1

581.3

338.8

umol/l

0.46

(1617658) Protocol used for examination of sentinel lymph nodes

149

1059

1.02

0.05

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

157

1.06

0.05

1.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

307

1.04

0.05

2.5

1.8

4.7

ug/l

1.00

194

(3028308) Erythrocytes [#/volume] in Pleural fluid

120

852

1.02

0.05

1.6

1.4

37052.1

37465.3

e6/l

0.01

476

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

279

1.04

0.04

1.6

1.3

53.6

62.4

0.72

231

(3023199) Leukocytes [#/volume] in Pleural fluid

129

944

0.99

0.03

1.5

3635.8

2265.4

e6/l

0.91

664

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

123

1.06

0.03

1.8

1.9

0.9

0.6

u/field

0.45

123

(3042010) Triglyceride [Moles/volume] in Pleural fluid

144

0.95

0.03

1.1

1.2

1.9

mmol/l

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

165

0.96

0.02

1.0

1.2

1.8

1.9

mmol/l

0.19

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

362

1.02

0.01

1.3

—

(3025577) Chromium [Mass/volume] in Blood

569

0.99

0.01

2.2

2.1

2.0

2.7

ug/l

1.40

480

(40765096) Chromosome analysis panel by Banding

323

0.98

0.01

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

184

0.98

0.00

1.2

1.3

89.3

262.7

ug/l

0.92

104

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.03

0.00

6.2

5.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

237

1.01

0.00

1.6

1.3

3.2

2.3

0.36

202

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

125

0.98

0.00

1.5

1.4

14.4

15.4

—

(3003577) Lead [Moles/volume] in Blood

135

1.02

0.00

1.2

1.5

0.2

umol/l

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.90

0.00

1.0

2.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.98

0.00

1.4

1.6

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.1

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.3

—

21.2

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: F5_DEPRESSION_RECURRENT – Recurrent or chronic depression

GWS hits: 18

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Recurrent or chronic depression

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Recurrent or chronic depression (F5_DEPRESSION_RECURRENT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints